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The binding of mono- and dinuclear platinum(II) complexes with both
double-stranded and G-quadruplex DNA (QDNA) was explored using
a combination of spectroscopic and computational techniques. The
stabilising effects on G-quadruplex DNA were assessed and structure-
activity relationships developed to guide the future development of
QDNA selective complexes.
Additionally, two pieces of software were developed, each able to
process spectroscopic information. The first application calculates
binding constants from various spectroscopic data including circular
dichroism and fluorescence. The second program, SOMSpec, uses a
machine learning approach to elucidate biomacromolecular structure
from circular dichroism and infrared spectra.
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Introduction
These works represent an overarching study into the interactions of small
molecules with biomacromolecules, such as DNA, for the purposes of understanding
and directing the design of bioactive platinum(II) complexes with improved
specificity, stabilisation properties and efficacy.1 My particular interest has been
in complexes which stabilise G-quadruplex DNA (QDNA). QDNA is formed from
guanine-rich regions of DNA such as the telomeres of eukaryotic DNA, regions
of linear non-coding d(TTAGGG)n tandem repeats.2 G-rich regions self-associate
through Hoogsteen base-pairing resulting in the formation of these non-canonical
QDNA structures.3 Importantly, the presence of these structures in vivo, particularly
within telomeric4 and oncogene promotor regions,5,6 represent potential targets
for the development of novel Platinum based anticancer agents.7 Select topologies
of these QDNA structures, which vary by sequence and length, are illustrated in
Figure 1.
This thesis is arranged into six chapters, the first five are each based on a particu-
lar facet of my outputs during my candidature, followed by a sixth ’Conclusions and
future work’ chapter. Chapter 1 begins by exploring the binding affinity of a series of
platinum(II)-phenanthroline complexes with double-stranded DNA (dsDNA) using
synchrotron radiation circular dichroism (SRCD). A significant outcome of this work
was the development of a new method to calculate equilibrium binding constants
and a software implementation to simplify the process.8 This laid the foundation
for exploring DNA interactions with a class of platinum(II)-terpyridine complexes,
as presented in Chapter 2.
In Chapter 2, I begin by evaluating the dsDNA and QDNA binding interactions
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Figure 1: G-quadruplex guanine tetrad consisting of Hoogsteen-bound guanine
bases stabilised by a central cation (left); schematics demonstrating the 5′–3′
arrangement of: (a) anti-parallel unimolecular; (b) anti-parallel bimolecular; and
(c) tetramolecular parallel QDNA.
of a series of dinuclear platinum(II)-terpyridine complexes I had synthesised in
my Honours year exhibiting QDNA affinity.9 Ultimately, it was discovered that
these complexes exhibited significant QDNA stabilisation, possessing impressive
selectivity.1 However, these complexes also were found to cause significant dsDNA
precipitation, so my attention was then focussed toward the factors necessary for
Pt(II) complexes to exhibit QDNA specificity. I also wanted to explore additional
biophysical approaches to investigating these binding interactions. This resulted in
the application of electrospray ionisation-mass spectrometry (ESI-MS) to a range of
Pt(II)-phenanthroline complexes, culminating in Chapter 3.
Chapter 3 involves revisiting the platinum(II)-phenanthroline complexes of
Chapter 1, where I investigated the interactions and selectivity of these with dsDNA
and QDNA. Through the application of ESI-MS, CD, and computational docking
simulations I was able to develop a greater understanding of the structure-activity
relationship exhibited by the planar phenanthroline moiety on the strength and
selectivity of binding with QDNA.
With the amount of CD and SRCD spectra obtained thus far I was curious of
alternative means for exploring this data. Chapter 4 presents my efforts in applying
more advanced computation methods to understanding biophysical data. In this
research, I developed a machine learning method for predicting protein secondary
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structure content from circular dichroism (CD) and also infrared (IR) and RAMAN
spectra. This approach was intentionally made flexible enough to be applicable to
other biophysical methods and with the acquisition of suitable training set data will
be applied to a wider range of problems in the future.
Finally, Chapter 5 presents additional outputs that were tangential to my main
research. Much of this was the result of collaborations where I contributed my
expertise in either spectroscopy, synthesis, visualisation, or computer simulation. It
includes additional published papers, conference proceedings, posters, and grants
awarded during my candidature.
As a proponent of research transparency and reproducibility a substantial
amount of my work presented here were created using only free software (specif-
ically GPLv2 or later licensed). This is why the software developed during my
candidature is GPLv3 licensed. It is important to define the phrase “free software”
so I’ll do so now—think “free” as in liberty, not “no cost”. As stated by the Free
Software Foundation (fsf.org) the four essential freedoms are: "The freedom to run
the program as you wish, for any purpose (freedom 0); The freedom to study how
the program works, and change it so it does your computing as you wish (freedom
1). Access to the source code is a precondition for this.; The freedom to redistribute
copies so you can help others (freedom 2).; The freedom to distribute copies of your
modified versions to others (freedom 3)."
To extend this same opportunity to others, I present here a subset of the software
which has enabled this goal. My operating system of choice is Fedora Workstation.
The computer I designed and built exclusively to handle my computational tasks,
Arrakis, runs Ubuntu LTS. Molecular docking was performed by Autodock Vina.10
Molecular dynamics simulations were all performed using GROMACS11 compiled
to enable CUDA acceleration, and prepared with a combination of Avogadro12
and UCSF Chimera,13 and analysed using VMD.14 I utilised Inkscape, GIMP, Krita,
and Blender for graphical work–particularly when generating the journal covers.
Finally, this thesis and several of my journal manuscripts were typeset in LATEX using
TeXstudio, in combination with the Zotero15 reference manager.
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Chapter 1
Improved DNA equilibrium binding
affinity determination of platinum(II)
complexes using synchrotron
radiation circular dichroism
Equilibrium binding constants are an important parameter used to assess many
biomacromolecules interactions with small molecules. These are often investigated
with a hope that they will correlate with biological activity and therefore provide
a rationale to drug design. As my research focussed on the development of DNA
binding small molecules it was imperative to be able to reliably and reproducibly
measure these binding interactions.
This work begins by showing why the contemporary models for calculating
binding affinity in biological systems are not representative of the physical phenom-
ena. The literature methods of Scatchard,16 Schmechel and Crothers,17 and others
determine the binding constant by extrapolating ligand concentration to zero. The
approach presented here considers and calculates binding data simultaneously at
all wavelengths of the experiment. In this work I chose to demonstrate the method
using synchrotron circular dichroism data, but the method is valid for any type
4
of spectroscopic data containing binding information such as fluorescence and has
been used successfully as such. Ultimately, I found that not only is this method far
faster at producing results, allowing for near real time experimental feedback, it
also revealed varying binding constant values across the various wavelengths. This
finding is best stated by quoting the manuscript:
“As SRCD spectra is the results from all the combined couplings of transitions of
all bases, we attribute the differences in K observed with changing wavelength to be a
consequence of the interactions at specific bases. Although this interaction will change
the overall spectra it may do more so in the region where the resulting couplings of the
transitions from this interaction dominate. This suggests that... the binding may be
more complex than this model is capable of describing as the definition is that K is a
constant across all wavelengths.”
As primary author, my contribution involved data acquisition, data analysis and
processing, together with the development and implementation of the underlying
code implementation—proof of concept code having been developed by Frank
Stootman. I produced all artwork and wrote a majority of the text. The code is
freely available, licensed under the GPLv2. This work was published in RSC Analyst
and has been cited 2 times (as of November 2019). As this work is applicable to
a broad range of researchers, the low citation count aludes to a challenge with the
accessibility of the method. Likely, this may be attributed to the requirements of
Mathematica and the need for a particular data format. This will be addressed in
a future revision of the software. It has also become an important teaching tool in
the third year undergraduate Pharmacological Chemistry unit at Western Sydney
University where it is used to demonstrate calculation of binding constants from
experimental fluorescence displacement data.
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Improved DNA equilibrium binding affinity
determinations of platinum(II) complexes using
synchrotron radiation circular dichroism†
Dale L. Ang,a Nykola C. Jones,b Frank Stootman,a Bahman Ghadiriana and
Janice R. Aldrich-Wright*a
The binding affinity of a series of square planar platinum(II) compounds of the type [Pt(AL)(IL)]
2+, where AL
is 1,2-diaminoethane and IL are 1,10-phenanthroline (phen), 4-methyl-1,10-phenanthroline (4Mephen),
5-methyl-1,10-phenanthroline (5Mephen), 4,7-dimethyl-1,10-phenanthroline (47Me2phen), 5,6-dimethyl-
1,10-phenanthroline (56Me2phen) or 3,4,7,8-tetramethyl-1,10-phenanthroline (3478Me4phen) has been
reinvestigated using Synchrotron Radiation Circular Dichroism (SRCD) spectroscopy. The additional peaks
exhibited considerably greater intensity than those observed between 200 and 400 nm affording
additional binding affinity determinations. In addition, the authors have reviewed the various mathematical
approaches used to estimate equilibrium binding constants and thereby demonstrate that their mathe-
matical approach, implemented with Wolfram Mathematica, has merit over other methods.
Introduction
Circular Dichroism (CD) spectroscopy is a well-established
method used for biophysical examination of chemical and bio-
logical structures, however, in conventional CD instruments
low flux of the light source in the far UV and vacuum UV wave-
lengths can limit the acquisition of information. These limi-
tations may be overcome using Synchrotron Radiation Circular
Dichroism (SRCD) spectroscopy.1,2 The application of synchro-
tron radiation to CD was first reported over 20 years ago, the
intense light source increasing effectiveness particularly as a
spectroscopic technique for both structural and functional
genomics.3,4 An additional advantage of SRCD includes the
ability to obtain data at shorter wavelengths encroaching into
the vacuum UV region, and as a result, superior structural
information.3
A comparison of the SRCD and conventional CD spectra of
ct-DNA (Fig. 1), illustrates the extended wavelength range of
SRCD. Note that the data is scaled to facilitate this comparison.
These intensely absorbing bands in the vacuum and far UV
region are seen for many compounds, including proteins and
other biomolecules.3,4 Chiral metal complexes (MCs), such as
[(5,6-dimethyl-1,10-phenanthroline) (1S,2S-diamino cyclo-
hexane) platinum(II)] dichloride (56MESS) and [(5,6-dimethyl-
1,10-phenanthroline) (1R,2R-diaminocyclohexane) platinum(II)]
dichloride (56MERR), also show additional intense absorption
bands well into the far UV (Fig. 2).
Equilibrium binding experiments are extensively used to
investigate interactions between small molecules and bio-
macromolecules, such as proteins and DNA.5–14 These inter-
actions may involve intercalation, H-bonding, van der Waals
Fig. 1 The spectra of ct-DNA as measured on a conventional CD (red)
and SRCD (green) spectrophotometer, where the spectra have been
scaled to allow direct comparison. CD spectrum was recorded between
200–350 nm, 35 µM, 1.0 cm path length, ambient temperature and 10
accumulations. SRCD spectrum was recorded between 170–350 nm,
1.1 mM, 0.01 cm path length, 25 °C and 3 accumulations.
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c5an00066a
aNanoscale Organisation and Dynamics Group, School of Science and Health,
University of Western Sydney, Penrith, NSW 2751, Australia.
E-mail: J.Aldrich-Wright@uws.edu.au; Fax: (+61) 246203025; Tel: (+61 ) 246203218
bISA, Department of Physics and Astronomy, Aarhus University, DK 8000 Aarhus C,
Denmark
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groove binding or π stacking. To evaluate the binding affinity
of related small molecules for a particular biomacromolecule
under specific experimental conditions the binding constant
Kb is determined; often using methods that poorly estimate
this value.
Determining an equilibrium binding
constant
The equilibrium binding constant (K) and the number of
bases per binding site (n) have heretofore been calculated
using a variety of methods as developed by Scatchard,15
Schmechel and Crothers,16 McGhee and von Hippel,17
Nordén,18,19 Wolfe et al.,20 Rodger,7,21–23 Rodger and
Nordén,24 and Kumar and Asuncion,25–27 among others. Some
of these approaches share a common assumption that artifi-
cially determines the binding constant at very low bound-
ligand concentrations (as demonstrated in the Supp data). Our
method,28 developed from first principles using the relation
LF þ SF  !
K
LB (where LF and SF are free ligand and free sub-
strate concentrations respectively and LB is the bound ligand
concentration) and represented in eqn (1), obtains a value of K
by accounting for the entire concentration range.











The fitting of eqn (1) to experimental data has been accom-
plished with a script (called a ‘notebook’) in Mathematica and
is given in the ESI.† Of note is that eqn (1) has a mathematical
point of inflexion which is indicated on the fitted curve as a
red dot if a valid fit is achieved.
In this work we initially use this method in Mathematica for
the fitting of eqn (1) to reprocess previously obtained CD
binding data for [(1,10-phenanthroline)(1,2-diaminoethane)-
platinum(II)] dichloride (PHENEN, 1) with ct-DNA to assure
that the results are consistent. We also demonstrate that the
method can also be used to determine the binding constant
for UV data. Finally, we interrogate recently obtained SRCD
binding data for ct-DNA and the platinum(II) complexes
PHENEN, (1), [(4-methyl-1,10-phenanthroline)(1,2-diamino-
ethane)platinum(II)] dichloride (4MEEN, 2), [(5-methyl-1,10-
phenanthroline)(1,2-diaminoethane) platinum(II)] dichloride
(5MEEN, 3), [(4,7-dimethyl-1,10-phenanthroline)(1,2-diamino-
ethane)platinum(II)] dichloride (47MEEN, 4), [(5,6-dimethyl-
1,10-phenanthroline)(1,2-diaminoethane)platinum(II)] dichlor-
ide (56MEEN, 5) and [(3,4,7,8-tetramethyl-1,10-phenanthro-
line)(1,2-diaminoethane)platinum(II)] dichloride (3478MEEN,
6) (Fig. 3) by using this improved method to observe what
effect the increased beam intensity and shorter wavelengths
contribute to the experimental results. Here we present a
method, implemented with Wolfram Mathematica, for the
quick and effective determination of the binding constant.
Experimental
Materials
All platinum(II) complexes were synthesised and characterised
as previously reported.5 Ct-DNA, disodium hydrogen phos-
phate, sodium dihydrogen phosphate sodium fluoride and
D-10-camphorsulfonic acid (CSA) were all purchased from
Aldrich Chemical Company. Aqueous solutions were prepared
with Milli-Q water (Millipore, MA). All other reagents and sol-
vents were of analytical grade.
Instrumentation
Conventional CD were recorded as previously reported.5 In
summary: a JASCO J-810 CD spectropolarimeter, at the
ambient temperature in the wavelength range of 200–350 nm,
at ct-DNA concentrations of 35 µM (2600 µL) and MC solution
of 10 mM, using a path length of 1 cm, a data pitch of 0.5 nm
with 10 accumulations. Aliquots of MC (1 µL) were titrated
into a cuvette containing the ct-DNA and the titration con-
tinued until no further change was observed in the CD spectrum,
indicating that the saturation point of the DNA had been
reached. Baseline subtraction was achieved by subtraction of
the ct-DNA/buffer spectrum.
SRCD spectra were recorded at the ASTRID synchrotron at
ISA, Aarhus University, Denmark (beamline CD1) operating at
Fig. 2 The SRCD spectra of 56MESS and 56MERR. Wavelength =
170–400 nm, concentration = 4 mM, path length = 0.01 cm. Inset: the
structure of 56MESS/56MERR, *denotes the chiral centres.
Fig. 3 The general structure of the platinum(II) complexes investigated.
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25 °C. The instrument was calibrated for magnitude and polari-
sation daily, using D-10-camphorsulfonic acid (CSA, 7.4 mg
mL−1). SRCD spectra were measured using a quartz cell of type
QS124 (Hellma GmBH, Germany) with a path length of
0.01 cm. Spectra were measured over the wavelength range
170–350 nm, using a slit width of 0.25 nm, a data pitch of
1 nm, and an average dwell time of 2.0 s. Spectra were averaged
from 3 accumulations and smoothed with the CD data proces-
sing software CDTool.29
A Thermo Scientific Evolution 300 UV-Vis spectro-
photometer, with a 1 cm quartz cell at room temperature scanning
over a 200–420 nm wavelength range, was used to determine
the concentration of CSA (ε285 nm = 34.6 M
−1 cm−1)30 and
ct-DNA (ε260 nm = 13 200 M
−1 cm−1).31 For all experiments
the ratio of the 192.5 : 290 nm peaks ranged between 2.04
and 2.06.
Binding experiments
Solution preparation. Some experimental changes to the
published methods were made in order to reinvestigate the
binding affinity of these platinum complexes with ct-DNA
using SRCD.5 Individual solutions (11 samples per experiment,
2 experiments per MC) were prepared for measurement to
determine affinity constants for the MCs with ct-DNA. The
DNA solution (1.1 mM) in phosphate buffer (3.6 mM) with NaF
(36 mM) at pH 7.1 and MC solutions (2 mM) were prepared.
Maintaining a constant volume of ct-DNA (220 µL), different
volumes MC solutions (2 mM) were prepared off-site prior to
the binding study (details in Table 1) and transported to the
Synchrotron. An aliquot from the titration mixture (usually 25
µL) was loaded onto the base of the demountable cell (Fig. 4)
by micropipette. The cover of the cell was then placed over
the solution with care to avoid bubble formation. All samples
were degassed before they were loaded into the cells. The
spectra were recorded over the range 170–350 nm with 3
accumulations.
Processing of data. Processing of the experimental data was
performed by fitting the data to eqn (1) across all wavelengths.
This was implemented using Wolfram Mathematica version 9.‡
Results and discussion
Model verification
As a quality assurance test of the implementation, the pre-
viously published CD ct-DNA titration spectra5,28 of 1 was re-
analysed (Fig. 5). The Mathematica notebook produces an
Table 1 Prepared solutions for SRCD DNA binding study
Tube no. Buffer/µL DNA/µL MC/µL Buffer/µL Total/µL DNA/mM MC/mM Ratio
0 300 0 0 0 300 0 0.00 0
1 — 220 0 80 300 1.1 0.00 0
2 — 220 1 79 300 1.1 0.07 0.06
3 — 220 1.5 78.5 300 1.1 0.10 0.09
4 — 220 2 78 300 1.1 0.13 0.12
5 — 220 2.5 77.5 300 1.1 0.17 0.15
6 — 220 3 77 300 1.1 0.20 0.18
7 — 220 3.5 76.5 300 1.1 0.23 0.21
8 — 220 4 76 300 1.1 0.27 0.24
9 — 220 5 75 300 1.1 0.33 0.30
10 — 220 6 74 300 1.1 0.40 0.36
11 — 220 12 68 300 1.1 0.80 0.72
Fig. 4 Assembly of demountable 0.01 cm quartz cell of type QS124 (Hellma GmBH, Germany).
‡The Mathematica binding notebook is provided in the ESI.† It can also be
obtained by contacting the corresponding author.
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interactive dialogue allowing the entire wavelength range to be
analysed and outputs this data in tabulated form. The results
for 1 are listed in Table 2. Selection of an appropriate wave-
length is evident when eqn (1) fits the curve, a red dot is
drawn at the point of inflexion, as shown in Fig. 5, thus provid-
ing an unbiased evaluation of the data. Previously, the binding
constant was determined to be 2.7 ± 0.2 × 105 at 211 nm using
the least squares method. Employing the method presented
here the binding constant was calculated to be 2.5 ± 0.1 × 105
at 212 nm which is in close agreement with the previously pub-
lished value.5
It is noteworthy that this equation does not always achieve
a valid fit of the experimental data. When the conditions are
met the observation that the calculated equilibrium binding
constant varies with wavelength is apparent and that not all
wavelengths produce a mathematically sound fit, highlighting
an important feature in our interpretation of the binding
model with eqn (1). This demonstrates an important pro-
gression as it removes any influence of subjectivity in the selec-
tion, calculation and reporting of binding constants. As shown
in the derivation of eqn (1) (ESI†), previous methods make
assumptions to simplify the calculations and as such can only
make approximations of the equilibrium binding constant at a
given wavelength. As SRCD spectra is the results from all the
combined couplings of transitions of all bases, we attribute
the differences in K observed with changing wavelength to be a
consequence of the interactions at specific bases. Although
this interaction will change the overall spectra it may do more
so in the region where the resulting couplings of the tran-
sitions from this interaction dominate. This suggests that the
data may suffers from experimental noise or that the binding
may be more complex than this model is capable of describing
as the definition is that K is a constant across all wavelengths.
The data collected from the conventional CD also includes
UV spectrum data which was likewise examined using the
Mathematica notebook producing the UV spectra illustrated in
Fig. 6. The inset depicts the response curves at peak maxima
227 and 274 nm which show that this data does not fit eqn (1).
In fact for this binding interaction there was no wavelength for
which a point of inflexion was obtained, i.e. the UV data does
fit eqn (1).
SRCD experiments
The SRCD spectra of 1–6 each with ct-DNA were obtained in
duplicate. The SRCD and induced SRCD (ISRCD) titration
spectra for 1 are shown in Fig. 7. For each MC, a previously
unseen and significantly more intense peak at ∼185 nm was
evident. The Mathematica notebook was used to interrogate
the spectra of each MC; the red dot on the binding curve indi-
cating a true fit of eqn (1). An example is illustrated in Fig. 7
(inset) with the data provided in Table 3 (Figures and Tables
for the duplicate experiment for 1 and for 2–6 are provided in
the ESI†). It is evident from this analysis that the resulting
SRCD data did not cover a comprehensive concentration
range; the samples were pre-prepared and transported to the
synchrotron for measurement with no facility for further
preparation. Despite this, the binding constant obtained at
211 nm was determined to be 1.6 ± 0.2 × 105 M with the
average K = 2.2 ± 0.3 × 105 M and n = 3.0 ± 0.1 across repeats.
Though slightly lower, this is comparable to the previously
reported CD value for 1.
Fig. 5 CD (left) and ICD spectra (right) at varying ratios of [MC]/[DNA] (listed) [Pt(en)(phen)]Cl2·2H2O into ct-DNA, PS buffer. Binding curve at
212 nm (inset). The solid line is a fit of eqn (1), K = 2.5 ± 0.1 × 105 M. The red dot, at the point of inflexion, indicates a good fit.
Table 2 Summary of successful fits of previously reported CD
spectra28 of 1 titrated into ct-DNA, as determined by Mathematica note-
book implementation of eqn (1), with associated error values and bases
per binding site
Wavelength (nm) K (× 105) n per complex
206.5 2.6 ± 0.1 3.8 ± 0.1
208.0 6.3 ± 0.4 3.2 ± 0.1
212.0 2.5 ± 0.1 3.7 ± 0.1
213.0 2.2 ± 0.1 3.8 ± 0.1
214.5 1.1 ± 0.1 5.0 ± 0.2
249.0 7.8 ± 0.1 1.1 ± 0.1
267.5 5.3 ± 0.2 2.6 ± 0.3
269.0 1.3 ± 0.1 2.8 ± 0.3
269.5 0.8 ± 0.1 2.8 ± 0.1
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The binding results from the SRCD (Table 4) are typically
an order of magnitude lower compared with those determined
from the CD binding data using the least squares method.
Whereas previously determined CD binding constants were
reported at a given wavelength (230 nm), a range of SRCD data
values satisfied the mathematical fit of eqn (1), thus the
average across all fitted wavelengths is reported. Despite the
limitations of the titration concentrations the program was
able to assess the binding affinity and number of binding sites
for 1–6 is comparable to previously reported values.
The small shift in wavelength at peak maxima, which is
apparent across all SRCD experiments, is attributable to DNA
Fig. 6 UV spectra at varying ratios of [MC]/[DNA]. 1 into ct-DNA in PS buffer. Titration curves at 227 and 274 nm (inset). The lack of a curve indicates
poor fit of eqn (1).
Fig. 7 Experiment A showing the SRCD and ISRCD spectra of varying concentrations of 1 with ct-DNA (1.1 mM) in 5 mM phosphate buffer, 50 mM
NaF at 7.5 pH. Binding curve determined at 186 and 211 nm (inset). The solid line is a fit of eqn (2); the red dot indicates a good fit.
Table 3 Complex 1 binding data from SRCD experiment
Wavelength
(nm) K × 105
n per
complex
186 0.11 ± 0.0a 3.0 ± 0.1
189 0.1 ± 0.0a 2.8 ± 0.1
192 0.1 ± 0.0a 3.4 ± 0.1
211 1.6 ± 0.4 2.4 ± 0.0a
228 0.6 ± 0.1 2.0 ± 0.0a
231 1.6 ± 0.3 2.2 ± 0.0a
257 2.7 ± 0.5 2.8 ± 0.1
264 0.3 ± 0.0a 2.1 ± 0.0a
a Error less than 0.03.
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conformational changes induced by the MCs. The intercala-
ting nature of the phenanthroline ligand causes elongation of
the DNA and is especially evident with 1–5. In previous
methods these subtle shifts are disregarded and a wavelength
value is chosen intuitively; this is avoided in our implemen-
tation as the fit may be at any wavelength provided that it is a
mathematically sound. This is symptomatic of the difficulty
with determining binding constants and is not always appar-
ent by using other methods.
The shoulder appearing at higher concentrations, seen in
Fig. 7 at ∼180 nm, is evident in all but the spectra of 6. This
suggests an additional mode of binding other than intercala-
tion. The binding of 6 may be by groove binding alone, the
tetramethylated phenanthroline being too large to insert
between the strands. This is also evidenced by the overall dis-
parity in the titration spectra between 6 and the other MCs.
Obtaining ideal SRCD spectra
Collecting data on CD instruments below 190 nm is limited by
a number of experimental conditions. The power of the syn-
chrotron beam can be several orders of magnitude brighter
than a Xenon lamp and does not experience a comparable flux
decrease across the UV and vacuum UV wavelength ranges. Any
reduction in light source intensity is amplified by absorptive
losses within the quartz optics, atmospheric oxygen in the
light path (despite nitrogen purging) as well as sample and
buffer absorption.32 These factors combine to limit the collec-
tion of meaningful data at wavelengths below 190 nm. Oxygen
is excluded from the light path of SRCD as it is under vacuum,
excepting the sample chamber which is constantly purged
with dry nitrogen. Measurements in aqueous solutions can be
extended down to 168 nm by short path length quartz sample
cells (typically 0.01 cm) and the judicious choice of buffer.32,33
The reduced sample volumes, accommodated by the improved
signal-to-noise, allow samples to be measured even in absorb-
ing buffers, lipids and detergents.
The shortest wavelength at which a spectrum can accurately
be measured (cut-off wavelength) is influenced by salts, par-
ticularly chloride, and buffer composition (Table 5). If the
components of the solution (i.e. buffers and salts) absorb
Table 4 Summary of DNA binding affinities of the Pt(II) complexes determined by conventional CD (as previously reported)5 and SRCD (using eqn (1))
CDa SRCDb
Compound Nm K × 106 N K × 105 n
1 [Pt(en)(phen)]Cl2·2H2O 230 2.2 ± 0.5 2.0 ± 0.3 0.9 ± 1.0 2.6 ± 0.5*
2 [Pt(en)(4-Mephen)]Cl2 230 1.2 ± 0.4 5.8 ± 1.1 1.8 ± 0.8 2.7 ± 0.6
3 [Pt(en)(5-Mephen)]Cl2 230 0.7 ± 0.2 3.8 ± 0.7 2.3 ± 1.0 3.6 ± 2.5
4 [Pt(en)(4,7-Me2phen)]Cl2 230 1.3 ± 0.4 4.6 ± 0.1 0.3 ± 0.1 2.3 ± 0.3
5 [Pt(en)(5,6-Me2phen)]Cl2 230 1.5 ± 1.1 4.9 ± 0.9 0.6 ± 0.4 3.0 ± 0.8
6 [Pt(en)(3,4,7,8-Me4phen)]Cl2 230 0.7 ± 0.3 6.0 ± 0.4 1.0 ± 0.9 6.1 ± 2.2
a The intrinsic approach and Scatchard model24 was used to determine K and n from the ct-DNA titration data. b Average of values across
wavelengths determined using the Mathematica notebook implementation.




Absorbance (10 mM solution, 0.1 cm path length cell)
180 nm 190 nm 200 nm 210 nm
NaF 170 >0.01 >0.01 >0.01 >0.01
KF 170 >0.01 >0.01 >0.01 >0.01
NaClO4 170 >0.01 >0.01 >0.01 >0.01
Boric acid 180 >0.01 >0.01 >0.01 >0.01
NaH2PO4 195 0.15 0.01 >0.01 >0.01
Na borate (pH 9.1) 200 0.3 0.09 >0.01 >0.01
NaCl 205 >0.5 >0.5 0.02 >0.01
Na2HPO4 210 >0.5 0.3 0.05 >0.01
Cacodylate (pH 6.0) 210 >0.5 0.22 0.20 0.01
Na acetate 220 >0.5 >0.5 0.17 0.03
Tris/H2SO4 (pH 8.0) 220 >0.5 0.24 0.13 0.02
HEPES/Na+ (pH 7.5) 230 >0.5 >0.5 0.5 0.37
MES/Na+ (pH 6.0) 230 >0.5 0.29 0.29 0.07
NaOH 230 >2 >2 >2 0.5
MOPS (pH 7.0) 230 >0.5 0.28 0.34 0.10
Tricine (pH 8.5) 230 >0.5 >0.5 0.44 0.22
EDTA* 230 >0.5 >0.5 0.42 0.20
aData are adapted from Kelly,32 Schmid.35 Additional data can be found in Rosenheck and Doty36 and Buck et al.37 *Data from this work.
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strongly in the region of measurement then it should be sub-
stituted with a non-absorbing equivalent. The worst informal
offender is chloride anion, so sodium chloride should be
replaced where possible by either sodium fluoride or sodium
sulfate. Buffers such as tris(hydroxymethyl)aminomethane
(Tris) can be acidified with phosphoric or sulfuric acid in place
of hydrochloric acid. Low pH buffers with carbonyl groups
(citrate, acetate and glycine) and neutral buffers such as
HEPES and tricine all absorb strongly, however low concen-
trations and short path length cells can minimise these effects
on spectra.32,34 Phosphate buffer (3.6 mM) replaced the Tris
buffer that had been used in the previous experiment. Concen-
trations of up to 100 mM in path lengths of less than 50 µm
can be used for a phosphate buffer.
While the concentrations of DNA and MC used in SRCD
experiments is higher than comparable CD experiments, they
are still relatively low (<∼1 mM) and the impact is minimal as
the obtained spectra are equivalent. This is somewhat expected
as the relative concentrations are equivalent and the viscosity
of the solutions still close to that of the solvent.
Conclusions
The DNA binding affinity of a range of metal complexes
was reinvestigated using SRCD and a new method was
implemented for determining the binding constants. The
implementation accommodates quick and effective determi-
nation of the binding constant across an entire spectrum,
and importantly the ability to observe the potential for error
in determining binding constants. The results compared
favourably to previous methods but also highlight the poten-
tial shortcoming of reporting binding constants at particular
wavelengths. Binding constants cannot, by definition, be
wavelength dependent and should be constant. We have pro-
vided the means to investigate the entire spectrum and in
doing so observed that the choice of wavelength makes a
difference. Ct-DNA has many binding sites and when one is
used up others will be occupied with different induced CD
signals. It is only when the shape of the induced CD spec-
trum is the same at the mixing ratios that the data can used
to determining binding constants. It is likely that the
spectrum is complicated by signals from other binding
interactions.
The Mathematica notebook implementation allows
immediate processing and feedback of experimental data
with the inclusion of an interactive spectrum navigator func-
tion and tabulated results. Implemented into an experi-
mental technique this automated process has the advantage
of avoiding insufficient or excessive data collection as well
as identification of which wavelengths the binding constant
can be determined with sufficient accuracy. Future refine-
ments to the data processing procedure are planned includ-
ing the ability to titrate DNA into a solution of MC and using
the integral of the curve. The notebook is available upon
request.
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complexes with flexible linkers
With an effective method to assess binding affinity developed and published,
there was now a need to assess the double-stranded DNA (dsDNA) binding
affinity of a series of platinum(II)-terpyridine complexes I had synthesised in
my Honours year. These were expected to have significantly higher binding
affinity and as a consequence improved biological activity over the platinum(II)-
phenanthroline complexes studied in Chapter 1. However, they proved to bind
almost quantitative to dsDNA through charge neutralisation with no apparent
specificity, resulting in precipitation of the DNA. I therefore hypothesised that these
planar molecules may preferentially stack with G-quadruplex DNA (QDNA) and
stabilise the structure. Preliminary CD melt tests revealed this to indeed be the
case, so I endeavoured to explore this phenomenon using various experimental and
computational approaches.
In this work the stabilisation effects of four dinuclear platinum(II)-terpyridine
complexes on QDNA and dsDNA was assessed. Techniques including synchrotron
radiation circular dichroism (SRCD), fluorescent intercalator displacement (FID),
14
and fluorescence resonance energy transfer (FRET) melt studies. The dinuclear
platinum(II)-terpyridine complexes, comprising two platinum(II) centres linked by
a flexible central ligand, were found to be strongly stabilising, and highly selective
for QDNA. The SRCD melting experiments showed up to 17◦C stabilisation of QDNA
melting temperature even in the presence of up to 600 fold excess of dsDNA.
As the primary author, my contribution involved synthesis of the complexes,
data acquisition at the ISA synchrotron in Denmark, QDNA melting data analysis
and processing, DFT and docking simulations, all artwork and graphics and writing
a significant component of the text. This work was published in Chemistry–A
European Journal and has been cited 22 times (as of November 2019). Importantly,
this work was considered a “Hot Paper” for impact and a back cover to the journal,
inspired by the work, was also published. The cover art can be found in Chapter 5.
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Quadruplex DNA-Stabilising Dinuclear Platinum(II) Terpyridine
Complexes with Flexible Linkers
Dale L. Ang,[a] Benjamin W. J. Harper,[a] Leticia Cubo,[b] Oscar Mendoza,[b] Ramon Vilar,*[b, c]
and Janice Aldrich-Wright*[a]
Abstract: Four dinuclear terpyridineplatinum(II) (Pt–terpy)
complexes were investigated for interactions with G-quadru-
plex DNA (QDNA) and duplex DNA (dsDNA) by synchrotron
radiation circular dichroism (SRCD), fluorescent intercalator
displacement (FID) assays and fluorescence resonance
energy transfer (FRET) melting studies. Additionally, compu-
tational docking studies were undertaken to provide insight
into potential binding modes for these complexes. The com-
plexes demonstrated the ability to increase the melting tem-
perature of various QDNA motifs by up to 17 8C and main-
tain this in up to a 600-fold excess of dsDNA. This study
demonstrates that dinuclear Pt–terpy complexes stabilise
QDNA and have a high degree of selectivity for QDNA over
dsDNA.
Introduction
Guanine-rich sequences of DNA have the ability to self-assem-
ble into non-canonical motifs such as G-quadruplexes (QDNA;
Figure 1). Bioinformatic studies have shown that over 360 000
DNA sequences within the human genome have the potential
to form QDNA[1] and in vitro experimental evidence supports
their formation in mammalian cells.[2] These quadruplex-form-
ing sequences are not randomly distributed, rather they are
over-represented in gene promoter regions, suggesting a caus-
ative link with transcription.[3] G-quadruplexes have also been
shown to assemble from the guanine-rich telomeric overhang
sequences. Studies have demonstrated that formation of
stable quadruplexes in telomeric regions prevents telomerase
(over expressed in greater than 85 % of cancer cells and plays
an important role in cancer cell immortalisation) from extend-
ing the telomere, resulting in growth inhibitory effects.[4] Con-
sequently there is growing interest in the development of
small molecules that can bind and stabilise QDNA motifs, and
in doing so, prevent unfolding of the secondary structure,
thereby interfering with telomerase activity.
Structural and spectroscopic evidence indicating that large
planar molecules interact with QDNA has been accumulated in
the last decade.[6] As has been discussed elsewhere,[7] planar
metal complexes are an attractive subclass of potential QDNA
binders, which exhibit favourable electrostatic and p-stacking
interactions with good solubility. In the mid-2000s, square
planar nickel(II)–salphen,[8] platinum(II)–terpyridine[9] and man-
ganese–porphyrin[10] complexes were reported to have high af-
finities towards QDNA. Since then, a significant number of
metal complexes have also been reported as effective bind-
ers[7] with most reported examples being of monometallic
complexes that form p–p stacking interactions with QDNA’s
guanine quartets. Although this has proven to be a successful
strategy, there is a push to develop metal complexes with
higher affinities and selectivity towards QDNA in comparison
with other topologies, such as duplex DNA (dsDNA). One ap-
proach has been to develop polymetallic systems that com-
bine the various modes of interaction into a single molecule
by incorporation of a second metal centre. One such example
is the combination of a known dsDNA intercalator, a plati-
num(II)–terpyridine moiety, with a dipicolyl- or cyclen-bound
copper(II) or zinc(II) to produce non-symmetric dimetallic com-
plexes.[11] These complexes were recently reported to possess
greatly enhanced selectivity towards QDNA, with up to 100-
fold preference over dsDNA.[11b] Several of these mixed dinu-
clear CuII, PtII and ZnII complexes showed cytotoxicities similar
to that of cisplatin and reinforced that the effort of combining
properties of various metals can be advantageous. The aromat-
ic and amine content of these compounds also substantiated
and reinforced the importance of electrostatic and p-stacking
interactions for selectively targeting QDNA.
Other polymetallic systems have been reported to demon-
strate improved characteristics over their mononuclear coun-
terparts. The PtII compound BBR3464, a cisplatin-like trinuclear
compound,[12] is a prime example of this effort. In preclinical
trials it proved more potent than cisplatin and effective against
cisplatin-resistant cell lines. Recent phase II clinical trials of
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BBR3464 have substantiated this cytotoxicity profile, the high
toxicity due to the formation of DNA adducts promoted by the
high flexibility of the molecule. A recent effort to modulate the
cytotoxicity of BBR3464-like compounds focused on creating
sterically hindered dinuclear complexes.[13] A significant reduc-
tion in reaction rate, and cytotoxicity in A2780 and A2780R cell
lines, resulted from the sterically hindered equivalents, howev-
er resistance was not overcome.
Dinuclear Ru complexes have also exhibited significantly im-
proved cytotoxicities in comparison to their mononuclear
counterparts.[14] With similarities to BBR3464, RuII–arene com-
pounds linked by bis(pyridinone) ligands of varying length
have reportedly varied in their lipophilicities, influenced by the
linker length with IC50 values similar to, and no cross-resistance
with, oxoplatin. Dinuclear ruthenium complexes with pro-
nounced QDNA binding affinities recently reported include the
chiral DD- and LL-[{Ru(phen)2}2(tpphz)]
4 + (tpphz = tetrapyri-
do[3,2-a :2’,3’-c :3’’,2’’-h :2’’’,3’’’-j]phenazine).[15] These complexes
have been shown to stack with the ends of QDNA with very
high affinity and, in doing so, exhibit strong luminescence. The
LL isomer is reported to bind approximately 40 times more
tightly than the DD isomer, suggesting a strong role in the
chirality and hence enantioselectivity with QDNA.
When studying the interactions of metal complexes with
DNA, a range of spectroscopic techniques may be applied;
simple UV/Vis titrations, fluorescent intercalator displacement
(FID) assays, fluorescence resonance energy transfer (FRET) and
circular dichroism (CD) melts are common. Although the re-
sults of these studies are highly valuable, recent developments
in both techniques and instrumentation involving synchrotron
radiation circular dichroism (SRCD) provides additional informa-
tion for the analysis of macromolecular interactions, including
secondary structural elucidation.[16] Although SRCD has been
known for some time, it has only more recently been utilised
for biological analysis, with instrumental refinement and cali-
bration enabling improved reproducibility.[17] Advantages of
SRCD over conventional CD for structural elucidation of bio-
molecules include the collection of additional data at shorter
wavelengths. The radiance of synchrotron radiation is many
orders of magnitude greater than that generated by xenon arc
lamps[18] with the resulting spectra providing additional elec-
tronic transitions facilitating the differentiation of more secon-
dary motifs and structures, which has proven particularly
useful for protein structural analysis.[19] Other advantages in-
clude the acquisition of spectra with improved signal-to-noise
ratios, and reduced sample size requirements.[20]
Herein we report the binding studies of four dinuclear Pt–
terpy metal complexes 1–4 (Figure 2) with QDNA and dsDNA.
Complexes 1–3 are dinuclear terpyridine-PtII joined by flexible
thiol bridging ligands of increasing length, while complex 4 is
joined by the flexible 4,4’-trimethylene-dipyridine ligand.[21]
SRCD melting experiments of the various QDNA motifs were
undertaken in order to determine relative binding affinity and
secondary structure stabilisation effects induced by the com-
plexes. The binding interactions of 2–4 were determined via
FID assays and FRET melting studies. Docking simulations were
also undertaken to provide insight into possible modes of
action. These complexes exhibited high affinity and good se-
lectivity for QDNA (human telomeric and c-Myc) over dsDNA.
Experimental Section
General procedures
All metal complexes were prepared as previously reported.[22] Buf-
fers were prepared from standard lab reagents. The SRCD experi-
ments were performed on three quadruplex-forming oligonucleo-
tides. The lyophilised oligos were purchased from DNA Technology
(Denmark): bimolecular Q1, 5’-(G4T4G3)2-3’, 22mer HTelo Q2, 5’-
(AG3(T2AG3)3)-3’, and 22mer human oncogene promoter c-myc Q3,
5’-(TGAG3TG3TAG3TG3TA2)-3’. These were annealed according to the
following protocol: the oligonucleotide was dissolved in potassium
phosphate buffer to approximately 1 mm, based on the manufac-
turer reported quantity, and heated at 95 8C for 15 min in a water
Figure 1. Left) QDNA tetrad of four Hoogsteen-bound guanine bases stabilised by a central cation; middle) examples of a two-strand and one-strand quadru-
plex structure; right) QDNA structure of human c-Myc promoter (PDB ID: 1XAV).[5]
Figure 2. Structure of the PtII–terpy complexes used in this study. 1–3 vary
by the dithiol linker lengths, whereas 4 includes a flexible propyl–dipyridyl
linker.[22] Counter ions omitted for clarity.
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bath. The solution was removed from the bath and allowed to
equilibrate to room temperature overnight. The stock solutions
were stored at 4 8C before use. The potassium phosphate buffers
used were KPB1 (10 mm, pH 7.0, 100 mm KF) for Q1 and KPB2
(25 mm, pH 7.0, 70 mm KF) for Q2 and Q3.
SRCD QDNA melts
Synchrotron experiments were performed at the Centre for Storage
Ring Facilities, Aarhus, Denmark (ASTRID and ASTRID2). QDNA
melting experiments were recorded from 5–85 8C in 5 8C intervals
with an equilibration time of 5 min at each temperature. Data as
averaged triplicate scans were collected from 170–350 nm in 1 nm
steps. Samples were loaded into a circular sealed 0.1 mm path-
length quartz cuvette. Determination of QDNA melting tempera-
ture (Tm) was achieved by plotting the peak intensity versus tem-
perature to give a sigmoidal curve. A stock solution of metal com-
plex (MC) in the same buffer as the oligo was added to the QDNA
solution to achieve a 1:1 MC/QDNA ratio. The QDNA concentration
was estimated from the HT of the SRCD scan at 25 8C using the e260
values derived by applying the Tataurov, You and Owczarzy
method.[23] The e260 = 105 100, 228 500 and 228 700 m
¢1 cm¢1 for Q1,
Q2 and Q3, respectively. The final volume was adjusted to 120 mL
with buffer, resulting in final concentrations of approximately 1 Õ
10¢4 m.
Oligonucleotides used for FID and FRET experiments
Stock solutions were prepared and used in the FID and FRET DNA
binding studies. The corresponding complex (2–4) was dissolved in
DMSO to give a 1 mm stock solution. All solutions were stored at
¢20 8C, defrosted and diluted immediately before use. Non-la-
belled oligonucleotides and fluorophore labelled oligonucleotides
of double HPLC-grade purity were purchased from Eurogentec
(Belgium). For the QDNA, the 21mer double-labelled oligonucleo-
tide F21T-HTelo, 5’-FAM-d(G3(T2AG3)3)-TAMRA-3’ (donor fluorophore
FAM, 6-carboxyfluorescein; acceptor fluorophore TAMRA, 6-carb-
oxytetramethylrhodamine) was used for FRET studies and the
22mer FID-HTelo 5’-(AG3(T2AG3)3)-3’ (identical sequence to Q2) for
FID studies. For c-Myc DNA, 22mer double-labelled pu22 myc oligo-
nucleotide F-myc-T, 5’-FAM-d(GAG3TG4AG3TG4A2G)-TAMRA-3’ was
used for FRET studies and the 21mer FID-myc 5’-G4AG3TG4AG3TG3-
3’ for FID studies. For dsDNA, the ds26 strand 5’-CAATCGGATC-
GAATTCGATCCGATTG-3’ was used for FID studies and the labelled
strand F-DS1-T, 5’-FAM-d(TATAGCTATA-T6-TATAGCTATA)-TAMRA-3’
for FRET studies. CT-DNA (sodium salt, Sigma-Aldrich) was used for
the FRET competition assay.
FID measurements
Stock solutions (20 mm) were obtained by dissolving the corre-
sponding oligonucleotide in MilliQ water, annealing to a 0.5 mm
concentration in potassium cacodylate buffer (60 mm, pH 7.4) at
95 8C for 5 min and allowing to cool slowly to room temperature
overnight. Thiazole Orange (TO; Sigma-Aldrich) was freshly pre-
pared as a stock solution (10 mm) in DMSO. Metal complexes and
TO were made up from stock solutions, to the final concentration
in a potassium cacodylate buffer (60 mm, pH 7.4). Measurements
were performed at a final 0.25 mm concentration of oligo, 0.5 mm
concentration of TO, with varied metal complex concentrations.
Samples were left to equilibrate for 3 min. Data was acquired at
room temperature over a range of l= 510–750 nm with excitation
at l= 501 nm.
FRET measurements
The labelled oligonucleotides F21T-HTelo, F-myc-T and F-DS1-T
(see above) were chosen for FRET evaluation. Two different buffers
were used for this assay: (a) a Caco.K90 buffer comprising lithium
cacodylate (10 mm, pH 7.4), KCl (10 mm) and LiCl (90 mm) for
F21T-HTelo and F-DS1-T oligos and (b) a Caco.K99 buffer compris-
ing lithium cacodylate (10 mm, pH 7.4), KCl (1 mm) and LiCl
(99 mm) for F-myc-T oligo. The labelled oligos were dissolved as
a stock 20 mm solution in MilliQ water and then annealed at
a 400 nm concentration in cacodylate buffer at 95 8C for 10 min
and allowed to cool slowly to room temperature overnight. Metal
complexes were dissolved from stock solutions to final concentra-
tions in the corresponding cacodylate buffer. Measurements were
performed on a RT-qPCR instrument (Agilent) with excitation at
l= 450–495 nm and detection at l= 515–545 nm. Each well of
a 96-well plate contained 200 nm oligo and metal complex to test.
Fluorescence readings were taken at intervals of 0.7 8C between
25–95 8C. The melting temperatures of F-DS1-T, F-myc-T and F21T-
HTelo were monitored in the presence of different concentration
of the metal complexes from 0.2–4.0 mm. Final analysis of the data
was carried out using OriginPro 8.5.
FRET competition assay
F21T-HTelo oligo was dissolved as a stock solution (20 mm) in
MilliQ water, then annealed as a 400 nm concentration in Caco.K
buffer [lithium cacodylate (10 mm, pH 7.4) and KCl/LiCl (10 mm/
90 mm)] at 95 8C for 10 min, and allowed to cool slowly to room
temperature overnight. A solution of CT-DNA (1.32 mg mL¢1) in
water was stirred gently for 3 days and then centrifuged for 3 min
(1200 rpm) to remove insoluble oligo. The concentration and
purity of the supernatant was determined by absorbance reading
on a CARY 300 BIO UV/Vis spectrophotometer and then diluted to
obtain the final concentrations. The corresponding metal com-
plexes were diluted from stock solutions to final concentrations in
cacodylate buffer. Each well of a 96-well plate was prepared with
a final 200 nm oligo concentration, 1 mm compound concentration,
and the CT-DNA concentration to test. Measurements were per-
formed under the same conditions as the FRET assay (see above).
For F-myc-T a 20 mm stock solution in MilliQ water was diluted
with Caco.K99 buffer.
DFT and docking Simulations
DFT Geometry optimisations of 1–4 were performed with Gaussian
09[24] in the gas phase at the B3LYP level of theory. The LANL2DZ
basis set and effective core potentials were used for the Pt atoms;
the 6-31G(d,p) basis set was used for all other atoms. The struc-
tures were created in Avogadro Version 1.1.1.[25] Preliminary geom-
etry optimisation was performed by using the Universal Force Field
(UFF).[26]
Docking simulations were performed by using SMINA docking soft-
ware, a fork of Autodock Vina Version 1.1.2.[27] The dsDNA,
d(CGCGAATTCGCG)2 (PDB ID: 1BNA), and the following NMR solu-
tion structures of representative QDNA: Q1 d(G4T4G4)2 (PDB ID:
156D), HTelo d(A3G3(T2AG3)3A2) (PDB ID: 2HY9), c-Myc
d(TGAG3TG3TAG3TG3TA2) (PDB ID: 1XAV) were used as the static
substrates. The predicted docking conformations with the most fa-
vourable binding energies were averaged to obtain the final result;
in all cases SD<0.5 kcal mol¢1. Further details are provided in the
Supporting Information.




It is well established that the annealing regimen used to pre-
pare QDNA is particularly critical to obtaining reproducible
conformations. Polymorphism has been shown to be kinetical-
ly governed and the cooling ramp is critical in obtaining repro-
ducible structures.[28] The key factor in preparation of Q1 was
allowing the sample to rest overnight; therefore progressing
towards the more thermodynamically favoured topologies.
This change was evidenced by changes in the relative intensi-
ties of the peaks at l290 and 263 nm, which stabilised after
storage to give the spectra shown in Figure 3. The appearance
of a positive maxima at 290 and 263 nm is indicative of anti-
parallel and parallel topologies, respectively. The alternating
syn- and anti-guanine conformations are suggested by the
peak at l= 263 nm, a positive maximum indicating a parallel
and a negative maximum indicating an antiparallel tract.[29]
Overall, these spectral signatures suggest that the final an-
nealed Q1 sample was a mixture of antiparallel, parallel and
hybrid topologies. The final relative peak heights of the posi-
tive peaks at 290 and 263 nm correspond with the expected
mixture of parallel, antiparallel and hybrid topologies for this
sequence under these annealing conditions.[28]
The extended wavelength range of SRCD revealed several
additional peaks compared with conventional benchtop CD
machine; five unique peaks were observed for Q1 (Figure 3,
left). The SRCD spectra show a reduction in intensity across all
peaks as the temperature is increased. The intensity changes
of these CD peaks were plotted against temperature to give
the melting curves shown in Figure 3 (right). The results re-
vealed somewhat varying Tm values for each of the wavelength
peaks.
Compounds 1–4 were each incubated with Q1 and the
melting process repeated. It was expected that as the metal
complex bound to the quadruplex it would be stabilised and
an associated increase in Tm would be observed. Additionally,
changes in the SRCD spectra would result if the binding in-
duced conformational changes in the quadruplex. The spectra
with compounds 1 and 2 did not vary noticeably from that of
the untreated Q1 prior to the beginning of denaturation. This
indicates that the metal complex interactions were likely sur-
face interactions; the resultant interactions induced little con-
formation change. However, compounds 3 and 4 appeared to
induce some spectral changes where the relative intensities of
the 290 and 264 nm peaks varied. A reduction in the intensity
of the 264 nm peak indicates a reduction in overall parallel
topology, or conversely a shift towards antiparallel structure;
a sign of inhomogeneity within the mixture. The isobestic
points and melt curves remained consistent throughout. The
presence of various topologies along with the variations ob-
served in melting temperature for each peak highlights the im-
portance of not simply averaging these results to obtain an
overall Tm but also, perhaps more enlighteningly, provides
some insight into the process of unfolding; the source of each
CD peak representing a structural feature which may be associ-
ated with ligand stabilisation. The Tm and DTm values are sum-
marised in Table 1.
These results reveal there is little contribution towards stabil-
ity of the positive peaks at l= 290 or 206 nm with compounds
1 and 4 showing only a modest 2.90.4 8C and 2.00.3 8C in-
crease in Tm, respectively. Interestingly, these are also the first
to denature, suggesting that these spectral signatures origi-
nate from the same structural feature: the bimolecular antipar-
Figure 3. Left) The SRCD spectra of Q1 at varying temperatures (average of three scans) ; right) the change in SRCD signal observed at each peak wavelength
as a function of temperature.
Table 1. Tm values for Q1 with sign and wavelength of each peak, and














Q1 36.70.1 42.20.1 50.91.1 38.30.4 48.60.6
DTm [8C]
1 2.90.4 1.00.4 6.44.8 0.21.0 4.21.1
2 0.30.3 11.21.6 2.52.5 ¢0.11.0 3.51.1
3 ¢0.10.4 2.90.5 21.312.0 ¢0.31.0 7.12.7
4 2.00.3 0.60.5 1.42.3 0.61.0 3.51.1
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allel quadruplex. This is understandable as the positive 206 nm
peak may be indicative of an antiparallel quadruplex and the
290 nm peak has been linked to the alternating quartet polari-
ty for this sequence type and also indicates antiparallel struc-
ture.[30] Complex 2 induced a change in Tm of 11.21.6 8C for
the 263 nm peak. The large errors in the results for the nega-
tive peak at l= 238 nm can be attributed to the low intensity
of the spectrum and the evident wavelength shift upon melt-
ing; it was therefore excluded from subsequent analysis, the
data being unreliable and of questionable utility. Lastly, single
stranded thymine tracks are typically resolved around l
190 nm,[31] hence the large positive peak at l= 188 nm for
this sequence. The increased melt temperature across all com-
plexes for the 188 nm peak suggests that it is a site of metal
complex interactions, likely due to the exposed thymine surfa-
ces. In summary, changes in Tm were most evident for the
peaks at l= 263 and 188 nm with 2 and 3, respectively, induc-
ing the greatest stabilisation. Due to limited instrument time,
subsequent investigations were performed with complex 2
and Q2 and Q3 only. The aim was to further investigate wheth-
er similar stabilisation was evident with the more biologically
relevant Q2 and Q3 quadruplex structures. The resulting melt-
ing spectra are shown in Figures 4 and 5 and the tabulated re-
sults are presented in Tables 2 and 3.
The 22mer Q2 (HTelo) is representative of the human telo-
meric sequence, which consists of tandem repeating units of
the single-stranded overhangs at the ends of chromosomes.
This sequence has a propensity to fold into unimolecular quad-
ruplex structures and in the presence of potassium cations has
a relatively high Tm of about 50 8C. The SRCD spectrum of Q2
shows a positive maximum peak at l= 292 nm and a corre-
sponding positive peak at l= 207 nm. These both signify an
antiparallel structure, as expected based on the reported NMR
structure.[32] The small shoulder at 250 nm is likely representa-
tive of some parallel structure, although as indicated by the
lower Tm could represent possible hybrid form resulting in an
inhomogeneous mixture with varying stabilities, as reflected in
the melting temperatures. Also evident are the characteristic
thymine single stranded loops with a positive maximum at l
189 nm. When treated with 2, increases are seen at l= 250
and 198 nm with DTm values of 12.73.5 and 10.13.9, re-
spectively. The 189 nm peak also undergoes a small increase in
Tm, as was seen with Q1.
Q3 is representative of the human c-Myc promoter, and
plays a role in promoting the transcription of the c-Myc onco-
gene.[33] Therefore is an important target for research as stabili-
sation of the quadruplex structure and subsequent suppres-
sion of the oncogene could lead to the development of new
anticancer agents.[34] The SRCD spectra of Q3 and of Q3 in the
presence of a 1:1 molar ratio of 2 are shown in Figure 5. The
NMR structure of Q3 is shown as an inset, comprising a unimo-
lecular primarily parallel-stranded topology in potassium solu-
tion.[5] A strong positive peak at l= 265 nm and negative maxi-
mum at l244 nm are strong indicators of parallel-type quad-
ruplexes.[29] The positive maximum at l= 207 nm and negative
Figure 4. Left) SRCD melt spectra of Q2 (inset: PDB ID: 2HY9) ; right) melt spectra of Q2 with compound 2.
Table 2. Tm values for Q2 with sign and wavelength of each peak, and














Q2 51.31.0 42.81.1 50.61.2 48.33.0 47.20.8
DTm [8C]
2 1.51.6 12.73.5 5.21.8 10.13.9 3.81.1
Table 3. Tm values for Q3 with sign and wavelength of each peak, and
DTm values determined by SRCD upon addition of metal complex 2.
Tm [8C]
QDNA/Complex 265 nm (+) 244 nm (¢) 207 nm (+) 185 nm (¢)
Q3 50.01.2 50.11.3 49.21.0 50.61.4
DTm [8C]
2 5.81.9 5.02.8 7.12.0 6.71.7
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maximum at l= 185 nm may be due to the lack of thymine
loops. Interestingly all four peaks possess melt temperatures
within 1 8C suggesting a strongly topologically homogeneous
solution. The lack of peak shift and clear isobestic points also
confirm the homogeneity of the solution.
Upon addition of 2, the melt temperatures all increase by
between roughly 5 and 7 8C, which is a lesser change than that
seen with Q1 and Q2 but consistent with stabilising interac-
tions. It is important to note the heating block within the in-
strument was unable to heat above 80 8C. This lack of addition-
al data resulted in a poorer fit of the data points and hence
larger errors, but it can be clearly seen in the SRCD spectrum
where some CD signal is present even at the highest attainable
temperature.
The stabilising effects of 1, the complex with the shortest
linker, on Q1 were modest, with a maximum observed DTm of
4.2 8C. Complexes 2 and 3, containing linkers of intermediate
length and with the potential for H-bonding interactions, dis-
played the largest quadruplex stabilisations, the greatest value
of DTm being 11.2 8C for 2. The potential for additional stacking
interactions of the dipyridyl linker of 4 was not reflected in the
Tm values with a maximum of DTm of 3.5 8C. For complexes 1, 3
and 4, the largest stabilising effect was on the positive 188 nm
peak, indicating interactions with the thymine loops, whereas
that for 2 was with the positive 263 nm peak, corresponding
to the parallel structure of the QDNA motif. These results indi-
cate that there may be an ideal length for optimal binding
with Q1, the increased linker lengths of 2 and 3 to both stack
and groove bind to the quadruplex motif. 1 lacks the length
and flexibility and thus may only stack at one end.[6c, 35] These
results are supported by literature reports identifying the im-
portance of planar metal geometry for binding and nucleic
acid self-assembly of Pt–terpy complexes with QDNA.[9,36]
FID Competition
Following on from the SRCD results, the binding affinities of
2–4 were screened by using fluorescent indicator displacement
(FID) assays to determine the affinity of the MCs towards
QDNA (HTelo and c-Myc ; see Experimental Section for details
of the sequences) and dsDNA. Compound 1 was not tested
due to its lack of activity (as established by SRCD melting ex-
periments), the poor solubility of the complex and its propen-
sity for precipitating dsDNA from solution. Upon addition of 2,
3 and 4 to the corresponding DNA structures previously incu-
bated with thiazole orange (TO), a concomitant decrease in
TO’s fluorescence intensity was observed (Table 4 and Fig-
ure S2 in the Supporting Information). The degree of displace-
ment of TO by these complexes, which in turn is a good indi-
cation of the ability of a compound to interact with a given
DNA structure, was evaluated from the concentration of the
compounds required to give a 50 % decrease in dye fluores-
cence (DC50 values, shown in Table 4). The DC50 values suggest
that the three complexes have high affinity (especially 2) to-
wards quadruplex HTelo and c-Myc DNA. These results reflect
the SRCD outcomes showing 2 inducing the greatest DTm. It is
generally accepted that molecules displaying DC50 values equal
to or less than 0.5 mm are excellent QDNA binders.
FRET melting assay
The ability of 2, 3 and 4 to stabilise QDNA was also investigat-
ed by using FRET assays (see Figures 6 and Figures S3 and S4
in the Supporting Information, respectively). Table 5 summaris-
es the DTm values ranging between 13.4 and 17.2 8C, confirm-
ing the good affinity of 2–4 towards these two QDNA motifs.
Figure 5. Left) SRCD melt spectra of Q3 (inset: PDB ID: 1XAV); right) melt spectra of Q3 with compound 2.
Table 4. DC50 values [mM] for c-Myc, HTelo and ds26 DNA determined by
FID upon addition of complexes 2, 3, and 4.
TO displacement (DC50) Selectivity (DC50)
Complex c-Myc HTelo ds26 ds26/c-Myc ds26/HTelo
2 0.160.01 0.290.03 0.880.01 5.5 3.0
3 0.460.03 0.940.03 1.190.10 2.6 1.3
4 0.420.03 0.640.10 0.950.10 2.3 1.5
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FRET competition assays were also carried out to study fur-
ther the selectivity displayed by these metal complexes. More
specifically, QDNA DTm values were measured for a fixed con-
centration (1 mm) of added metal complex in the presence of
an increasing excess of CT-DNA (0.6 mm to 120 mm). Figure 7
summarises the result of the competitive FRET assay. The data
demonstrates the selectivity of these complexes as the DTm
values of F-myc-T and F21T-HTelo did not decrease upon addi-
tion of up to 300-fold excess of CT-DNA (competitor) to la-
belled QDNA (60 mm base pair concentration). Particularly no-
ticeable is the ability of 4 to selectively stabilise F-myc-T even
at higher concentrations of CT-DNA (120 mm, equivalent to
a 600-fold excess), since the F-myc-T QDNA melting tempera-
ture does not decrease. In the case of 2 and 3, no changes in
QDNA melting temperature (for either sequence studied) were
observed for up to 6 mm CT-DNA. However, addition of 120 mm
CT-DNA (equivalent to 600-fold excess) decreased the melting
temperatures by between 5 and 8 8C. Once again, QDNA stack-
ing interactions dominate and are especially evident for 4 with
the aromatic linker.
Computational studies
Analysis of the docking results revealed that 1 exhibited poor
affinity for both types of DNA, self-stacking in preference to
DNA interaction in all docking runs. With the dsDNA substrate
(Figure 8), 2 and 3 displayed an affinity for the minor groove;
the linkers of both 2 and 3 sitting deeply along the minor
groove of dsDNA. This effect has been seen in previous dock-
ing studies.[37] With 4, the major groove was preferred. In each
case, the terpyridine moieties participated in an edge-to-face
stacking interaction with the aromatic base residues. The link-
ers lay along the grooves of the DNA, whereas the more posi-
tively charged Pt centres interacted preferentially with regions
of the negatively charged DNA backbone or aromatic residues.
With respect to the QDNA interactions of 2–4 (Figure 9),
there is an apparent affinity between Pt and the central cavity,
effectively taking the place of the K+ ions; the Pt–terpy moiety
is clearly end-stacking with the QDNA structure. This interac-
tion has been suggested to have a vital effect on stabilising
these QDNA.[38] The second metal centre typically lies in the
groove, where there are likely electrostatic interactions be-
tween the metal centre and the widely exposed negatively
charged backbone. The enhanced affinity of 4 for QDNA may
also be attributed to the stacking interactions of the linker.
Overall, these results suggest that the aromatic linker of 4 im-
proved the affinity for QDNA through increased potential to p-
stack with exposed bases of the QDNA structure, whereas the
chain lengths of 2 and 3 are optimal for face and groove inter-
actions. Although not reflected in the absolute predicted bind-
ing values, it is clear that the increased planar surface area and
positive charge contribute to the overall affinity with QDNA.
The binding energies with dsDNA and QDNA are summarised
in Table 6.
Figure 6. FRET melting results of experiments carried out with F-myc-T (top),
F21T-HTelo (middle) and F-DS1-T (bottom) with increasing concentration of
4 (0–4 mm).
Table 5. DTm values for F-myc, HTelo and ds26 DNA determined by FRET
upon addition of compounds 2, 3, and 4.
DTm [8C]
Complex F-myc-T F21T-HTelo F-DS1-T
2 13.51.4 17.21.6 1.21.0
3 15.01.3 17.10.8 0.30.1
4 14.80.3 13.40.2 0.80.1
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Conclusion
The process of identifying small molecules that bind to and
stabilise biologically relevant quadruplex structures is an area
of intense interest; with this study we have demonstrated that
dinuclear Pt–terpy complexes exhibit such properties. They
possess the ability to bind and stabilise QDNA structures, in-
creasing the melting temperatures by up to about 13 8C, while
not significantly affecting the conformation, as evidenced
through SRCD experiments. The SOS-linked 2 was shown to
favour the parallel topologies of Q1 and Q2 as evidenced by
the large increase in Tm : 11.2 8C for the positive 263 nm peak
of Q1 and 12.7 8C for the positive 250 nm peak of Q2. Similar
results were obtained for the FRET studies with compounds 2,
3 and 4 all increasing the Tm by up to 17 8C for QDNA but only
a marginal increase of between 0.3 and 1.2 8C for dsDNA. The
FID experiments confirmed that the DC50 of 1 was 0.16 mm to-
wards c-myc with all compounds below 0.5 mm. Competitive
FRET experiments confirmed these findings, with compound 4
exhibiting especially high selectivity towards QDNA in the
presence of up to a 600-fold concentration of dsDNA, while no
decrease in the Tm of the QDNA was observed.
Additionally, SRCD spectra of the melting profiles for both
HTelo (Q2) and c-Myc (Q3) motifs were recorded and analysed
at biologically relevant buffer concentrations. Finally, through
molecular modelling experiments, the potential stabilisation ef-
fects through stacking and electrostatic interactions were vi-
sualised. The predicted binding energies mirrored the findings
of the experimental methods applied herein.
Further work towards extending this study to the other
linked compounds 1, 3 and 4 for further SRCD studies (when
access allows) and further molecular dynamics simulations in-
Figure 7. FRET competition experiments of selected complexes at 1 mm concentration showing the reduction of F-myc and F21T-HTelo DNA melting tempera-
ture with increased concentration of CT-DNA.
Figure 8. Predicted docking positions for MC–dsDNA interactions. Overview
of minor and major groove binding: a) Complex 3 ; b) complex 4. Close up
views of the interactions: c) complex 4 ; d) complex 2 ; e) complex 3.
Figure 9. Predicted docking positions for MC–QDNA interactions. Overviews
of the stacking interactions with Q1: a) Complex 2 ; b) complex 3 ; c) com-
plex 4 (PDB ID: 156D). d) Side view and e) overview of interactions of 4 with
c-Myc (PDB ID: 1XAV).
Table 6. Summary of results for docking simulations of 1–4 with sub-
strates dsDNA and QDNA.
Predicted Binding Energy DGSD [kcal mol¢1]
dsDNA QDNA
Complex 12mer Q1 Q2 (HTelo) Q3 (c-Myc)
1 – – ¢6.40.1 ¢6.90.0
2 ¢5.70.0 ¢8.30.1 ¢6.70.1 ¢6.20.1
3 ¢8.30.1 ¢7.90.1 ¢6.30.1 ¢7.30.4
4 ¢9.30.0 ¢10.00.0 ¢7.60.2 ¢9.10.0
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cluding simulated annealing would assist in further elucidating
the modes of interaction. Additionally, substituted terpyridine
moieties could improve selectivity towards QDNA motifs. Final-
ly, the solubility of these compounds must be addressed; likely
areas for this are different counter ions or the addition of solu-
bilising groups. Work is already underway, with some progress
made towards more selective complexes of this type.
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Chapter 3
A study of Pt(II)-phenanthroline
complex interactions with
double-stranded and G-quadruplex
DNA by ESI-MS, circular dichroism,
and computational docking
Expanding on my previous work applying SRCD and other spectroscopic tech-
niques, I was intrigued by the idea that mass spectrometry could be used to study
the binding of small molecules with biomacromolecules such as DNA and proteins.
Due to the harsh ionisation processes typically required in mass spectroscopy,
resulting in fragmentation of the analyte of interest, a milder ionisation method
is required. Electrospray ionisation (ESI) is a relatively soft ionisation process
where a strong electric field is applied to a nebulised flow of liquid, creating a
fine aerosol of charged ions in the gas phase. These charged particles are attracted
to the oppositely charged spectrometer inlet where they are analysed.
ESI is the predominant method of ionisation when the analyte of interest is in
25
liquid, as is the case when coupled to a liquid chromatography system. In this way
biomacromolecules such as DNA and proteins may survive intact and be observed
without fragmentation. The application of ESI-MS is not a quantifiable method
but a hierarchy of binding may be developed for a series of small molecules. My
initial training in the technique was performed by our colleagues at Wollongong
University. From there it was developed in house with the assistance of the mass
spectrometry facility in the School of Medicine.
An alternative ionisation method to ESI is matrix-assisted laser desorp-
tion/ionization (MALDI). Both are considered soft ionisation methods, with
resultant low fragmentation of analytes, but MALDI is less likely to produce
multivalent ions due to the ionisation mechanism. This may limit the detection
of higher molecular weight analytes, as is the case for G-quadruplex complexes
with molecular weights often >8000 Da. ESI has also been found to produce
higher resolution spectra with lower degree of fragmentation when applied to the
investigation of platinum complexes with biomacromolecules.18 The identity of ions
resulting from the ESI-MS experiments are readily deconvoluted with the number
of bound complexes and included ammonium ions observable.
In this work, a range of platinum(II)-phenanthroline complexes matching those
in Chapter 1 were synthesised and characterised according to literature method.
A new method of preparing DNA for ESI-MS analysis was developed and applied
successfully, along with several computational techniques and CD incubation stud-
ies. One of the outcomes of this study showed that the ESI-MS experiment binding
affinity correlated with the published known binding strengths, therefore showing
that ESI-MS can be applied to qualitatively determine the binding characteristics of
these platinum(II)-phenanthroline complexes. I performed all experimental work,
DFT and docking simulations, generated all artwork and graphics and wrote the
entirety of the text.
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Abstract
The binding interactions of a series of square planar platinum(II)-phenanthroline complexes of the
type [Pt(PL)(AL)]2+ (where PL = variously methyl-substituted 1,10-phenanthroline (phen) and AL =
ethane-1,2-diamine (en)) were assessed with a G-quadruplex DNA (5′-TTG GGG GT-3′, G4DNA) and a
double-stranded DNA (5′-CGC GAA TTC GCG-3′, dsDNA) sequence by ESI-MS. The results indicate a
strong correlation between G4DNA affinity and increasing phenanthroline methyl substitution. Circu-
lar dichroism (CD) spectroscopy and molecular docking studies also support the finding that increased
substitution of the phenanthroline ligand increased selectivity for G4DNA.
1 Introduction
In the presence of appropriately sized cations, guanosine-rich DNA regions self-assemble to form pla-
nar guanine tetrad structures, commonly referred to as G-quadruplex DNA (G4DNA).12,20 The nature
and importance of these non-canonical DNA structures is becoming increasingly apparent with early
estimates on the number of G-quadruplex-forming sequences in the human genome of ∼20,000.25
More recent efforts to estimate the number of possible G-quadruplex forming sequences have sig-
nificantly revised this number to well over 300,000.7 Combined with the discovery that G4 motifs
are also present in heterochromatin,18 compounds that selectively target and bind these unique DNA
structures may lead to new and innovative chemotherapeutic strategies.38
Approximately half of all chemotherapeutic regimens involve platinum-based compounds and cis-
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platin is the leading treatment.29 The typical mode of action of platinum complexes is to form DNA
adducts with the N7 of guanine, interfering with replication, causing cell death. The non-selective
nature of these chelates often results in debilitating side effects and the development of resistance.
As such, there is a strong focus to develop small molecules that selectively target non-canonical DNA
motifs such as G4DNA to achieve higher efficacy while reducing negative side-effects.8
The various structural topologies afforded by G4DNA open up numerous targeting opportunities.
Conceptually, by stabilising the G4DNA structures selectively, the transcription of genes such as the
c-myc oncogene9,33 and even telomerase activity, may be modulated.13 Recently, regulation of gene
expression, by manipulating the stability of a modified G4DNA, was demonstrated in zebrafish em-
bryos.27 The technique involved reversible cis–trans photoisomerisation of a photochromic nucleobase
to induce a hyperstable G4DNA state that inhibited transcription. Dinuclear Pt(II)-terpyridine com-
plexes have been shown to stablilise G4DNA melting temperatures by up to 17 °C, suggesting similar
inhibition effects may be possible with Pt(II) complexes.1
In vitro experimental evidence, as obtained by linear dichroism, suggests that the chief mode of
interaction between planar aromatic cationic metal complexes and double-stranded DNA (dsDNA) is
via intercalation.30 In contrast, G4DNA, with strongly interacting strands and an internal cationic core,
would be expected to be relatively immune to intercalation: stacking and groove binding interactions
would dominate. Previous investigations with a subset of these platinum complexes (PCs) examined
interactions with G4DNA at extremely high PC:DNA ratios and found the square-planar geometry to
be critical to stacking interactions and thus favourable with the planar tetrad G4DNA structures.35
Figure 1 The six square planar Pt(II)-phenanthroline complexes studied, along with the abbreviated naming
conventions used. All were prepared as dichloride salts according to literature methods.10
Here we report the interactions of a range of biologically active square planar PCs comprising a sub-
stituted 1,10-phenanthroline (phen) pharmacophore, IL, together with an achiral bidentate ethane-
1,2-diamine (en) ancillary ligand, AL. Table 1 lists the IC50 (inhibitory concentration) values (L1210,
murine leukemia cell line) and dsDNA binding constants (Kb) for these complexes.10 Through the
application of ESI-MS binding experiments, circular dichroism spectroscopy, and molecular docking
simulations we present evidence that planar molecular surface area is a critical component of effective
G4DNA interactions. Additionally, the contribution of lipophilicity to G4DNA binding is considered.
Finally, a streamlined purification method is presented, simplifying the method and reducing the time
and cost of preparing DNA oligomers for ESI-MS experimentation.
Table 1 List of IC50 values,10 dsDNA binding constants, Kb,10 HPLC retention time, and predicted binding
affinity. *Errors were < 0.1 kcal/mol
ID Complex IC50 (µM, L1210) Kb×106 (230 nm) Retention time (k′, min) ∆G (kcal/mol)*
– Cisplatin 0.5 – – –
1 [Pt(en)(phen)]Cl2 9.7±0.4 2.2±0.5 4.736 –6.4
2 [Pt(en)(4-mephen)]Cl2 > 50 1.2±0.4 5.788 –6.8
3 [Pt(en)(5-mephen)]Cl2 2.8±0.8 0.7±0.2 5.938 –6.5
4 [Pt(en)(4,7-me2phen)]Cl2 > 50 1.3±0.4 6.828 –6.5
5 [Pt(en)(5,6-me2phen)]Cl2 1.5±0.3 1.5±1.1 6.987 –6.8
6 [Pt(en)(3,4,7,8-me4phen)]Cl2 > 50 0.7±0.3 8.434 –6.9
2 Results and Discussion
2.1 Preparation of oligomers for ESI-MS
G4DNA is stabilised by the presence of K+ ions within the central cavity of the tetrads. Substituting K+
with Na+ adversely affects the stability of the G4 structure due to the smaller ionic radius of Na+ (K+
= 138 pm, Na+ = 102 pm). Conveniently, the ammonium ion (NH+4 ) is an excellent substitute for K
+
as the ionic radius for NH+4 is∼140 pm.32,34 In our experience, the G4DNA stability of the K+ and NH+4
adducts are similar, as measured by melting temperature. It is important to minimise the presence
of Na+ and K+ salt adducts when preparing highly anionic nucleic oligomers for sensitive techniques
such as ESI-MS; these adducts interfere to such an extent that it is difficult to quantify the results ef-
fectively. Therefore, it is necessary to replace these with a volatile salt before analysis—ammonium in
the form of ammonium acetate buffer. To this end, contemporary DNA oligomer purification methods
for ESI-MS experiments are time consuming. These processes usually consist of combining multiple
HPLC injections (to limit column overloading) in ammonium acetate buffer followed by concentrating
the collected fractions down to a single sample; this process typically requires several days and leads
to inevitable sample loss.
We introduce a simple and robust purification/cation exchange step that retains purity and min-
imises sample loss, using a commercially available cation exchange column coupled to a peristaltic
pump and simple UV detector. The column was first saturated with ammonium acetate buffer, the
G4DNA loaded, subsequently eluted, and then lyophilised as one fraction. The total process, exclud-
ing the lyophilisation step, can be completed within 30 min. Typically, multiple Na+ and K+ salt adduct
peaks are observed in ESI mass spectra. The absence of these factors in the negative ion mass spectra
(Figure 2) is evidence of this refined method. D2 was subjected to the same chromatographic purifi-
cation and cation exchange process. In the spectrum for D2 (Figure 2 upper) m/z 1214.2, 1821.9, and
2429.8 were assigned to [ssD2−3H]3−, [D2−4H]4−, and [D2−3H]3−, respectively. Some unassignable
peaks are observed, however the intensities are <20% of the total ion current (TIC). Peak tailing, sig-
nifying adducts of mostly K+ and Na+, is minimal. A peak assignable to the 3− charge state at m/z
2429.8 is also visible but at a very low ion count. The G4 spectrum is similarly assignable. Ions of high
abundance at m/z 1674.7 and 2009.8 are assigned to [G4+4NH+4 −10H]6− and [G4+4NH+4 −9H]5−
respectively with the predominant ions in the 6− and 5− charge states. There are no non-assignable
peaks is this spectra and minimal adducts. Individual spectra are provided in the SI.
Figure 2 Negative ion ESI-MS spectrum of D2 (upper) and G4 (lower). D2: Peaks at m/z 1214.2, 1821.9, and
2429.8 were assigned to [ssD2−3H]3−, [D2−4H]4−, and [D2−3H]3− ions, respectively. G4: Peaks at m/z
1674.7, and 2009.8 correspond to the [G4+4NH+4 −10H]6− and [G4+4NH+4 −9H]5− ions, respectively.
2.2 Interactions of platinum(II) complexes with double-stranded and G-quadruplex DNA
The PCs analysed were chosen as they demonstrate in vitro anticancer activity and the dsDNA binding
constants have been quantified (Table 1).10 The series exhibit structurally distinct modifications to
the planar aromatic ligand, specifically the number and position of methyl moieties. This provides
the ability to compare the effects of these modifications from a structure activity relationship (SAR)
analysis perspective, directly. Furthermore, these PCs are well-characterised, very stable in solution,
and contain no chiral centres that may interfere with CD analysis. The G4 and D2 oligomer sequences
were chosen in order to provide thermodynamically stable non-covalent structures unlikely to dissoci-
ate during drug binding. High G/C content D2, and a previously reported G4 were chosen specifically
for this purpose.6
To begin with, the interactions of 5 with G4 were examined using negative ion ESI-MS (Figure 3).
An important point to make is that with increasing concentrations of 5 the intensity of the free G4
5− ion (red circle, m/z 2010.0) decreases visibly but does not disappear entirely. The abundance of
ions where one PC is bound (green triangle, m/z 2102.2) stays relatively stable, and is the dominant
ion across all concentration ratios. This is followed closely by two PCs bound to the G4 (blue square,
m/z 2194.5) and lastly at the very high 10:1 PC:DNA ratio, the three PCs bound G4 ion is clearly
evident at (pink diamond, m/z 2286.0). Across the board, the binding affinity with G4 shows that
as the phenanthroline methylation increases, so too does G4DNA binding (Figure 4).When exposed
to the PCs with dimethylated phenanthrolines, 4 and 5, there is less than 20% free G4 remaining at
the highest concentration, bested only by tetramethylated phenanthroline PC (6) which shows strong
interaction at all ratios. Nonetheless, there remains a detectable portion of free G4 in solution even
at the highest concentrations of PC.
When the ESI mass spectra of D2 with the PCs are examined, it becomes readily apparent that the
5:1 ratio is more than adequate to fully bind all available DNA, resulting in no discernible free D2 ion
intensity. At the 1:1 PC:D2 ratio PCs 2, 4, and 5 demonstrate the highest affinity with ∼30% unbound.
This is followed by 3 with ∼45% unbound, and lastly 1 and 6 with ∼50% unbound D2 at this ratio.
The experimental Kb values for dsDNA also reflect this trend (Table 1). It is hypothesised that with
limited planar surface area for intercalation, in this scenario groove binding and electrostatic interac-
tions dominate, resulting in a reduced chance of surviving the ionisation process required for ESI-MS
analysis. PC 6 also interacts poorly; the width of the tetra-methylated phenanthroline ligand sterically
limits access to the intercalation site. At concentrations of 5:1 PC:DNA and above, all available dsDNA
was bound to a PC.
G4 binding follows a different trend: at all PC:G4 ratios, the trend for binding follows 1 < 2 < 3
< 4 ' 5 < 6. When we consider the surface area of the aromatic ligand it is clear there is a direct
association with G4 binding affinity. It is of note that even at 10:1 PC:G4 ratios there is still >10%
free unbound DNA. The possible cause of this is that the ESI process imparts too much energy for the
low binding affinity of the PC:G4 association to survive intact. A summary of the ESI-MS results of
PCs 1–6 with G4 (upper) and D2 (lower) presented as a percentage of free unbound DNA (calculated
Figure 3 Negative ion ESI mass spectra of free G4 and solutions containing G4 with increasing PC:G4DNA
ratios with 5. (a) G4 only; (b) 1:1; (c) 5:1; (d) 10:1. Red circle: G4 only; green triangle: G4 + 1PC; blue
square: G4 + 2PC; pink diamond: G4 + 3PC.
from the sum of all relative ion intensities) are presented in Figure 4.
From these results it can be summarised that the factors which favour binding with D2 are not
necessarily the same as those that contribute to G4 affinity. As the most favourable G4 binder, 6, is
equal poorest with 1 when interacting with D2. The appearance of free G4 ions even at the highest
ratios of PCs also suggested that the types of interactions with G4 are far weaker than interactions
with D2. A likely explanation for this trend is that intercalation is not feasible within the G4 structure,
leaving only groove binding and stacking interactions as possible alternatives. Groove binding and
stacking require lower binding energy and therefore are inherently less stable than intercalation and
so less likely to survive the ionisation process.
It should be noted that at high PC concentrations, as in the case of 10:1 PC:DNA experiments here,
ion suppression may be a factor affecting the validity of the mass spectra observed. Ion suppression
occurs when the metal complex is more readily ionised than the DNA phosphate groups, resulting
Figure 4 Percentage of free D2 and G4 at various PC:DNA ratios for each of the PCs studied, as measured
by ESI-MS.
in preferential ionisation, effectively stealing the charge.2,3,11 This was observed as a lowering of
the overall S/N ratio of the spectrum. Additionally, non-volatile components make droplet formation
or droplet evaporation less efficient which, in turn, affects the amount of charged G4 reaching the
detector. This phenomenon is exacerbated as PC:DNA ratios increase.
2.3 Induced Circular Dichroism by metal complex
In order to observe if any change in structure occurred, G4 was treated with each PC at what may be
considered saturation (10:1 PC:G4) and a CD spectrum measured (Figure 5 upper). A positive peak
at 213 nm, negative peak at 244 nm and strong positive peak apparent at ∼265 nm are all indicative
of parallel quadruplex formation19 and is observed clearly in these CD spectra. Upon the addition
of PCs, conformational changes are apparent; loss of CD signal magnitude follows the sequence 1
(phen) < 2 (4phen) < 3 (5phen) = 5 (56phen) < 4 (47phen) < 6 (3478phen). When the stacking
interaction sites are filled, additional interaction through groove binding occurs, thereby elongating
the G4 structure, with a resulting loss of optical activity and reduction in magnitude.
The appearance of a shoulder at∼300 nm is noteworthy as it is absent in the free G4, and increases
in intensity with the increasing binding affinity of the PCs. This is in agreement with the behaviour
observed when a ruthenium dipyridophenazine (dppz) complex was incubating with a similar parallel
G-quadruplex sequence at a 4:1 ratio of metal complex resulting in the DNA adopting an antiparallel
topology.24 The conformational change induced by the PC supports the conclusions in the ESI-MS
studies where 4 and 6 bind most strongly at these high ratios, so much so that they induce a change
in the G4 structure.
The induced CD spectra (ICD, Figure 5 lower) (the G4+PC CD spectrum minus the G4 CD spec-
trum) increases proportional to molecular surface area. PCs 3 and 5 exhibit near identical ICD, which
is as expected as each is methylated in the 5 position (5-methylphen and 5,6-dimethylphen ligands,
respectively). Across all PCs, all peaks decrease in intensity proportionally with the strength of bind-
ing, as supported by the ESI-MS results. From the ICD it is evident that the reduction in magnitude of
all peaks, and in particular the ∼265 nm peak, equates to an overall reduction of parallel quadruplex
structure.
2.4 Hydrophopbicity determination by Reverse-Phase HPLC
Reverse-phase HPLC (RP-HPLC) is a separation technique which uses a non-polar C18 stationary and
polar mobile phase. This results in the preferential partitioning between the two phases based on
molecular hydrophobicity. The more hydrophilic the analyte, the more it would partition into the
polar mobile phase, reducing retention times. Using this principle, the measured retention time of a
series of related analytes provides a first order estimate of the relative hydrophobicity of a compound.4
Table 1 lists the corrected retention time, k′, of each PC. PC 1 elutes first (4.74 min) followed by
the monomethyl substituted 2 and 3 (5.79 and 5.94 min, respectively), then the dimethyl substituted
4 and 5 (6.83 and 6.99 min, respectively) and finally tetramethyl-substituted 6 (8.43 min). This
increase in elution time can be attributed to the increasing surface area of the phen moiety, and the
electron density and charge distribution of the complex.
Correlating retention time with percent bound DNA (at a 1:1 PC:DNA ratio) provides an insight
into binding specificity. For G4 there is very strong correlation (Pearson correlation coefficient (PCC)
= 0.98, R2 = 0.9778), contrasting with very low correlation for D2 (PCC = 0.14, R2 = 0.0205)
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Figure 5 CD (upper) and induced circular dichroism (ICD, lower) spectra of G4 incubated with PCs at 10:1
MC:DNA ratio in buffer (NH4OAc, pH 7.0) at an oligomer concentration of 5 µM. Samples were incubated at
room temperature for 1 h prior to measurement. Cell pathlength 0.1 cm, 1 nm data pitch, 100 nm min−1 scan
speed, 20 accumulations. Data were smoothed once with a 7 point Savitzky-Golay algorithm.
(Figure S19). However, if PC 6 is excluded from the correlation calculation, the D2 correlation im-
proves substantially to 0.89. This highlights the specificity of 6 for G4, qualifying the tetra-methylated
phenanthroline moiety for investigation in future G4 selective binders.
2.5 Computational docking and DFT
Docking simulations were performed using the representative PDB structures 1BNA for D2 and 2JT7
for G4 (Figure 6). The rigid structure of the square planar complexes equates only a small confor-
mational sampling space for the docking simulations. It was expected that the conserved ethane-1,2-
diamine moiety would contribute in a generally equal way to the overall binding affinity across the
complexes and resulted in extremely reproducible docking binding energy and conformation predic-
tions across replicates (<1% variation). This thereby restricted the study wholly to the contribution
of the substitution effects of the phenanthroline moiety. Predicted binding energy results of the com-
putational docking are summarised in Table 1. The predicted binding generally follows 1 < 3 ' 4 < 2
' 5 < 6, a slight deviation from the retention time and ESI-MS results. These theoretical predictions
generally follow the substitution of the phenanthroline.
Figure 6 The models used in the docking simulations. Side view (a) and top view (b) of G4 tetramolecular
parallel quadruplex (PDB ID: 2JT7); (c) 12mer D2 (PDB ID: 1BNA).
Analysis of the predicted binding conformations (Figure 7) reveals a subtle interplay between
electrostatic and hydrophobic/π-stacking interactions. The non- and mono-methylated PCs (1, 2, and
3) interact with the G4 via groove binding with the methyl moiety oriented inwards, away from the
bulk water, while the positively charged en moiety is observed to interact with the negatively charged
backbone phosphates. This is in contrast to what is seen with the di- or tetra-methylated PCs (4, 5 and
6) where the effect of an increased neutral hydrophobic region dominates in the interaction, resulting
in a preference for stacking with the top and/or bottom tetrads formed by the guanine bases. Thus,
the increased hydrophobic surface area of the methylation drives the interaction towards a preference
for stacking over groove binding. The strong stability of these parallel tetramolecular quadruplexes
precludes the capacity for intercalation, which is the predominant form of interaction of these PCs
with double-stranded DNA.10
The distribution of partial atomic charges is summarised as a boxplot (Figure S20) and the cal-
culated electrostatic potential visualised as an isosurface (Figure S21). Figures S20 & S21 serve to
Figure 7 Selected poses of predicted docking conformations of the PCs (1–6) with G4DNA PDB 2JT7.
illustrate that the subtle change in charge distribution is attributable to the degree of methylation,
and in the interaction with G4 this manifests as a transition from groove binding to π-stacking. Polari-
sation and π-stacking interactions have been shown to be influenced directly by substituents,28 which
is demonstrated here with the increasing methylation reducing the charge density on the central plat-
inum atom. The dominant charges are those for the platinum (∼+0.72) and the two nitrogens of the
phenanthroline (∼–0.67 each). The majority of the remaining positive charge is carried by the cen-
tral phenanthroline carbons (atoms 3, 7, 8, 14) and the ethane-1,2-diamine carbons (atoms 17, 18).
As expected, the largest fluctuations in charge are from the carbons where the methyl substituents
attach (atoms 4, 5, 10, 11, 12, and 13). Therefore, it is readily apparent that the methyl substituents
play a role in the overall ESP. The calculated Mulliken charges are listed in Table S3. Overall, the
molecular charge is heavily biased towards the en moiety with methylation affecting the charge distri-
bution. Increasing methylation shifts the charge density towards the en moiety, exposing more neutral
phenanthroline surface and hence biasing stacking interactions over the more electrostatically driven
groove binding.
3 Conclusions
Here we analysed, with the application of ESI-MS, molecular docking simulations and associated
techniques, how the variously methyl-substituted planar aromatic phenanthroline moieties in a series
of platinum(II) complexes interact with dsDNA and G4DNA. Also presented is a fast method for the
preparation of DNA for use in ESI-MS experiments. The results highlight some important structural
characteristics required in designing a new generation of chemotherapeutic agents to target G4DNA.
Specifically, that lipophilic aromatic pharmacophores play an important role in binding with G4DNA,
likely primarily through a π-stacking mechanism with the tetrad. This may mean modulating the
π-stacking effect and charge distribution through variously charged substituents.
Interestingly, there is little correlation between the published IC50 values of the PCs tested and
specificity towards G4DNA. Conversely, a strong correlation between the lipophilicity of the complexes
and binding was observed for G4DNA but not dsDNA. The main in vitro mode of action of these PCs is
by interaction with the cytoskeletal proteins, resulting in stalled cell replication leading to cell death.21
This is fortuitous as it highlights that features optimal for this type of interaction are not necessarily
the same as required for G4DNA binding. Furthermore, these PCs may shed some light on possible
leads for further functionalisation with the ultimate goal of highly specific targeting of G4DNA.
Despite the docking analysis of PCs 1–3 showing groove binding, the experimental CD evidence
suggests end-capping as the main mode of interaction for these PCs. In general, platinum(II) com-
plexes are classified as G4DNA end-capping with tetrad π-stacking type binding.22 The discrepancy
can be attributed to limitations of the docking simulations of this type with rigid substrates. However,
it still captures a very important trend in that methylation of the phenanthroline plays a role in the
end-capping interactions, as complexes 4–6 display.
While this family of PCs are a starting point for understanding G4DNA binding from a structural
perspective, derivatives of similar square planar metal complexes have demonstrated greater affinity
for the planar tetrad structure of G4DNA.14 Platinum(II) is a strong candidate due to being more
stable than equivalent Ni(II) and Pd(II) complexes,5,26,31 and ability to be oxidised to a Pt(IV) prodrug
which then reduces to the active form in vivo.15 However, we have not considered the possibility of
further interactions with the G4DNA structure at this point. Hydrogen bonding plays a critical role
in biomolecular interactions and selectivity may be improved with strategically placed H-bond donors
and acceptors. Future work will expand the range of G4DNA substrates studied through further
synthesis and molecular dynamics simulations on these systems.
4 Experimental
4.1 Pt(II) complexes
The PCs, presented in Figure 1, were prepared by literature methods as dichloride salts.37 The PoraPak
Rxn CX columns were purchased from Waters. The oligomer 5′-TTG GGG GT-3′ (G4, 2496.7 Da) was
purchased from GeneWorks, Thebarton, South Australia. The self-complementary oligomer 5′-CGC
GAA TTC GCG-3′ (D2, 3646.4 Da) was purchased from DNA Technology, Denmark. Ammonium
acetate was purchased from APS Chemicals and HPLC grade acetonitrile, methanol and DMSO from
Merck chemicals.
4.2 DNA purification and cation exchange
The dsDNA (D2) was composed of the self-complementary oligomer 5′-CGC GAA TTC GCG-3′, and the
G4DNA (G4) oligomer sequence was 5′-TTG GGG GT-3′. Oligomer purification and cation exchange
were performed using a Waters Porapak Rxn CX 20 cc column. A constant flow rate of 1 mL min−1 was
controlled using a Bio-Rad low pressure peristaltic pump and detection was achieved with an inline
Bio-Rad UV detector at 260 nm. The column was prepared by eluting methanol (10 mL) then wa-
ter (20 mL), followed by equilibration with ammonium acetate solution (100 mL, 150 mM, pH 7.0).
DNA, as supplied, was dissolved in ammonium acetate buffer (NH4OAc, 300 µL, 150 mM, pH 7.0).
The DNA solution was loaded onto the equilibrated column and eluted with buffer so that the peak
could be collected. The resulting ∼5 mL purified DNA solution was lyophilised. Final concentration
of the DNA was spectrophotometrically determined by UV absorbance using the following molar ab-
sorptivities: G4 ε260 = 76,000 M−1 cm−1, D2 ε260 = 191,500 M−1 cm−1. Concentrations were then
adjusted to achieve a stock concentration of 1 mM. The final tetramolecular G4 and double-stranded
D2 DNA were obtained by annealing in a water bath at 95 °C for 5 min and cooling naturally to room
temperature over several hours. Final concentrations of the annealed DNA stocks were confirmed
spectrophotometrically and stored at 4 °C prior to use.
4.3 ESI-MS
Mass spectra were obtained in ESI negative mode using a Waters XEVO QToF ESI mass spectrometer
with a Z-spray ionisation source. Spectra were obtained with an MCP potential of 2.4 kV, a cone
voltage of 25 V, capillary tip potential of 2.3 kV and the extraction cone at 4.0 V. The desolvation
gas (nitrogen) flow was 150 L hr−1 at 150 °C, cone gas flow 20 L hr−1, with a source temperature of
70 °C. Sample solutions were infused using a KD Scientific Model 100 syringe pump, at a flow rate
of 5 µL min−1. A lockspray solution of 200 pg µL−1 leucine enkephalin in 50% aqueous acetonitrile
plus 0.1% formic acid was infused at 5 µL min−1 simultaneously, in order to enable mass accuracy
correction. All sample spectra were obtained in ESI negative ion mode over a 50–4000 m/z range.
MassLynx v4.1 was used for the processing of spectra. A 5 min window of the total ion chromatogram
was combined, and the region from 1200–3000 m/z chosen so as to encompass all visible charge
states. All samples were prepared at 1:1, 5:1 and 10:1 PC:DNA ratios, vortexed and adjusted to a final
volume of 25 µL. The solutions were vortexed and equilibrated at room temperature for 5 min before
infusion. DNA concentration in each sample was 10 µM. The solution was vortexed and equilibrated
at room temperature for 5 min before infusion.
4.4 Circular dichroism
Circular dichroism (CD) spectra (200–400 nm) were obtained using a Jasco J-810 spectropolarime-
ter and 0.1 cm pathlength quartz cell, a data pitch of 1 nm, scan speed of 100 nm min−1 and 20
accumulations. Data were smoothed once with a 7 point Savitzky-Golay algorithm. Solutions were
prepared at a 10:1 PC:G4DNA ratio in buffer (NHOAc, pH 7.0) at an oligomer concentration of 5 µM
and incubated at room temperature for 1 h prior to measurement.
4.5 HPLC
Analytical reverse-phase HPLC (RP-HPLC) of the PCs was performed on an Agilent Technologies 1260
Infinity, equipped with a Phenomenex C18 reverse phase column (4.6 × 150 mm, 5 µm). The mobile
phase consisted of solvent A (0.06 % TFA in water) and solvent B (0.06 % TFA in ACN:H2O (90:10)).
In each case 10 µL samples were injected and eluted with a gradient of 0–40 (% B) over 15 min at a
flow rate of 1 mL min−1. Detection was by photodiode array at 254 and 214 nm. Reported retention
times are corrected by subtracting the elution time of a non-retained compound.
4.6 Computational methods
Computational binding affinity and docking analysis was performed using a custom version of AutoDock
Vina.36 The substrate DNA models were based on the protein data bank structures G4 (PDB ID:
2JT7)23 and D2 (PDB ID: 1BNA).16 The search space was specified so as to encompass the entire sub-
strate. Five runs of each docking were performed, the results averaged and the PCs ranked by reported
binding energy. The predicted docking conformations with the most favourable binding energies were
averaged to obtain the final result; in all cases SD < 0.1 kcal mol−1. DFT geometry optimisations
and Mulliken population analysis were performed with Gaussian 0917 in the gas phase at the B3LYP
level of theory. The LANL2DZ basis set and effective core potentials were used for the Pt atoms; the
6-31G(d,p) basis set was used for all other atoms. Mulliken charges are the reduced form—hydrogens
are summed into the heavy atoms. Input files are listed in the supplementary information.
5 Acknowledgments
Thanks to WSU Mass Spectrometry Facility for access to the ToF mass spectrometer. Thanks also to
WSU Summer Scholarship students Yuliani Yuliani and Sandy Craze for contributions to the experi-
mental component and Dr Elise Wright for helpful discussions. D.L.A. was supported by an Australian
Postgraduate Award with WSU topup.
6 Conflicts of interest
The authors declare that they have no conflict of interest.
References
1 Ang DL, Harper BWJ, Cubo L, Mendoza O, Vilar R, Aldrich-Wright J (2016) Quadruplex DNA-
Stabilising Dinuclear Platinum(II) Terpyridine Complexes with Flexible Linkers. Chemistry – A
European Journal 22(7):2317–2325, DOI 10.1002/chem.201503663
2 Annesley TM (2003) Ion Suppression in Mass Spectrometry. Clinical Chemistry 49(7):1041–1044,
DOI 10.1373/49.7.1041, 00933
3 Antignac JP, de Wasch K, Monteau F, De Brabander H, Andre F, Le Bizec B (2005) The ion suppres-
sion phenomenon in liquid chromatography–mass spectrometry and its consequences in the field
of residue analysis. Analytica Chimica Acta 529(1–2):129–136, DOI 10.1016/j.aca.2004.08.055,
00224
4 Ayouni L, Cazorla G, Chaillou D, Herbreteau B, Rudaz S, Lantéri P, Carrupt PA (2005) Fast Deter-
mination of Lipophilicity by HPLC. Chromatographia 62(5):251–255, DOI 10.1365/s10337-005-
0608-6
5 Bandeira S, Gonzalez-Garcia J, Pensa E, Albrecht T, Vilar R (2018) A Redox-Activated G-
Quadruplex DNA Binder Based on a Platinum(IV)–Salphen Complex. Angewandte Chemie
International Edition pp 310–313, DOI 10.1002/anie.201709968@10.1002/(ISSN)1521-
3773.EuroBIC14
6 Beck JL (2011) Developments in Electrospray Ionization Mass Spectrometry of Non-Covalent
DNA–Ligand Complexes. Australian Journal of Chemistry 64(6):705–717, 00002
7 Bedrat A, Lacroix L, Mergny JL (2016) Re-evaluation of G-quadruplex propensity with G4Hunter.
Nucleic Acids Research 44(4):1746–1759, DOI 10.1093/nar/gkw006
8 Betzer JF, Nuter F, Chtchigrovsky M, Hamon F, Kellermann G, Ali S, Calméjane MA, Roque S,
Poupon J, Cresteil T, Teulade-Fichou MP, Marinetti A, Bombard S (2016) Linking of Antitumor
trans NHC-Pt(II) Complexes to G-Quadruplex DNA Ligand for Telomeric Targeting. Bioconjugate
Chemistry 27(6):1456–1470, DOI 10.1021/acs.bioconjchem.6b00079
9 Biffi G, Tannahill D, McCafferty J, Balasubramanian S (2013) Quantitative visualization of DNA G-
quadruplex structures in human cells. Nature Chemistry 5(3):182–186, DOI 10.1038/nchem.1548
10 Brodie CR, Collins JG, Aldrich-Wright JR (2004) DNA binding and biological activity of some
platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines. Dal-
ton Transactions (8):1145–1152, DOI 10.1039/B316511F, 00052
11 Buhrman DL, Price PI, Rudewiczcor PJ (1996) Quantitation of SR 27417 in human plasma us-
ing electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppression.
Journal of the American Society for Mass Spectrometry 7(11):1099–1105, DOI 10.1016/S1044-
0305(96)00072-4, 00307
12 Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S (2006) Quadruplex DNA: Sequence, topology
and structure. Nucleic Acids Research 34(19):5402–5415, DOI 10.1093/nar/gkl655, cited by 0637
13 Charif R, Granotier-Beckers C, Bertrand HC, Poupon J, Ségal-Bendirdjian E, Teulade-Fichou MP,
Boussin FD, Bombard S (2017) Association of a Platinum Complex to a G-Quadruplex Lig-
and Enhances Telomere Disruption. Chemical Research in Toxicology 30(8):1629–1640, DOI
10.1021/acs.chemrestox.7b00131
14 Davis KJ, Richardson C, Beck JL, Knowles BM, Guédin A, Mergny JL, Willis AC, Ralph SF
(2015) Synthesis and characterisation of nickel Schiff base complexes containing the meso-1,2-
diphenylethylenediamine moiety: Selective interactions with a tetramolecular DNA quadruplex.
Dalton Transactions 44(7):3136–3150, DOI 10.1039/C4DT02926G
15 Deo KM, Ang DL, McGhie B, Rajamanickam A, Dhiman A, Khoury A, Holland J, Bjelosevic A, Pages
B, Gordon C, Aldrich-Wright JR (2018) Platinum coordination compounds with potent anticancer
activity. Coordination Chemistry Reviews 375:148–163, DOI 10.1016/j.ccr.2017.11.014
16 Drew HR, Wing RM, Takano T, Broka C, Tanaka S, Itakura K, Dickerson RE (1981) Structure of a
B-DNA dodecamer: Conformation and dynamics. Proceedings of the National Academy of Sciences
78(4):2179–2183, 00775 PMID: 6941276
17 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone
V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J,
Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima
T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery Jr JA, Peralta JE, Ogliaro F, Bearpark MJ,
Heyd J, Brothers EN, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Ren-
dell AP, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam NJ, Klene M, Knox JE, Cross
JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R,
Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannen-
berg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009)
Gaussian 09. Gaussian, Inc.
18 Hoffmann RF, Moshkin YM, Mouton S, Grzeschik NA, Kalicharan RD, Kuipers J, Wolters AHG,
Nishida K, Romashchenko AV, Postberg J, Lipps H, Berezikov E, Sibon OCM, Giepmans BNG,
Lansdorp PM (2016) Guanine quadruplex structures localize to heterochromatin. Nucleic Acids
Research 44(1):152–163, DOI 10.1093/nar/gkv900
19 Holm AIS, Kohler B, Hoffmann SV, Brøndsted Nielsen S (2010) Synchrotron radiation
circular dichroism of various G-quadruplex structures. Biopolymers 93(5):429–433, DOI
10.1002/bip.21354, 00000
20 Huppert JL, Balasubramanian S (2005) Prevalence of quadruplexes in the human genome. Nucleic
Acids Research 33(9):2908–2916, DOI 10.1093/nar/gki609
21 Kostrhunova H, Zajac J, Novohradsky V, Kasparkova J, Malina J, Aldrich-Wright JR, Petruzzella
E, Sirota R, Gibson D, Brabec V (2019) A Subset of New Platinum Antitumor Agents Kills
Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization
of the Microtubule Cytoskeleton. Journal of Medicinal Chemistry 62(10):5176–5190, DOI
10.1021/acs.jmedchem.9b00489
22 Liu W, Zhong YF, Liu LY, Shen CT, Zeng W, Wang F, Yang D, Mao ZW (2018) Solution structures of
multiple G-quadruplex complexes induced by a platinum(II)-based tripod reveal dynamic binding.
Nature Communications 9(1):1–11, DOI 10.1038/s41467-018-05810-4
23 Martino L, Virno A, Pagano B, Virgilio A, Di Micco S, Galeone A, Giancola C, Bifulco G, Mayol
L, Randazzo A (2007) Structural and Thermodynamic Studies of the Interaction of Distamycin A
with the Parallel Quadruplex Structure [d(TGGGGT)]4. Journal of the American Chemical Society
129(51):16048–16056, DOI 10.1021/ja075710k, 00064
24 McQuaid K, Abell H, Gurung SP, Allan DR, Winter G, Sorensen T, Cardin DJ, Brazier JA, Cardin CJ,
Hall JP (2019) Structural Studies Reveal Enantiospecific Recognition of a DNA G-Quadruplex by a
Ruthenium Polypyridyl Complex. Angewandte Chemie International Edition 58(29):9881–9885,
DOI 10.1002/anie.201814502
25 Morel E, Poyer F, Vaslin L, Bombard S, Teulade-Fichou MP (2016) Photoactivatable plat-
inum(II) terpyridine derivatives for G-quadruplex DNA double anchoring. Inorganica Chimica Acta
452:152–158, DOI 10.1016/j.ica.2016.02.033
26 Morel E, Beauvineau C, Naud-Martin D, Landras-Guetta C, Verga D, Ghosh D, Achelle S, Mahuteau-
Betzer F, Bombard S, Teulade-Fichou MP (2019) Selectivity of Terpyridine Platinum Anticancer
Drugs for G-quadruplex DNA. Molecules 24(3):404, DOI 10.3390/molecules24030404
27 Ogasawara S (2018) Transcription Driven by Reversible Photocontrol of Hyperstable G-
Quadruplexes. ACS Synthetic Biology 7(11):2507–2513, DOI 10.1021/acssynbio.8b00216
28 Parrish RM, Sherrill CD (2014) Quantum-Mechanical Evaluation of π–π versus Substituent-π In-
teractions in π Stacking: Direct Evidence for the Wheeler–Houk Picture. Journal of the American
Chemical Society 136(50):17386–17389, DOI 10.1021/ja5101245, 00000
29 Reedijk J, Lohman P (1985) Cisplatin: Synthesis, antitumour activity and mechanism of action.
Pharmacy World & Science 7(5):173–180, DOI 10.1007/BF02307573, cited by 0082
30 Rodger A, Dorrington G, L Ang D (2016) Linear dichroism as a probe of molecular structure and
interactions. Analyst 141(24):6490–6498, DOI 10.1039/C6AN01771A
31 Sabharwal NC, Mendoza O, Nicoludis JM, Ruan T, Mergny JL, Yatsunyk LA (2016) Investigation of
the interactions between Pt(II) and Pd(II) derivatives of 5,10,15,20-tetrakis (N-methyl-4-pyridyl)
porphyrin and G-quadruplex DNA. JBIC Journal of Biological Inorganic Chemistry 21(2):227–239,
DOI 10.1007/s00775-015-1325-8
32 Shannon RD, Prewitt CT (1970) Revised values of effective ionic radii. Acta Crystallograph-
ica Section B: Structural Crystallography and Crystal Chemistry 26(7):1046–1048, DOI
10.1107/S0567740870003576
33 Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH (2002) Direct evidence for a G-quadruplex in a
promoter region and its targeting with a small molecule to repress c-MYC transcription. Proceed-
ings of the National Academy of Sciences 99(18):11593–11598, DOI 10.1073/pnas.182256799,
00952
34 Sidey V (2016) On the effective ionic radii for ammonium. Acta Crystallographica Sec-
tion B: Structural Science, Crystal Engineering and Materials 72(4):626–633, DOI
10.1107/S2052520616008064
35 Talib J, Green C, Davis KJ, Urathamakul T, Beck JL, Aldrich-Wright JR, Ralph SF (2008) A com-
parison of the binding of metal complexes to duplex and quadruplex DNA. Dalton Transactions
(8):1018–1026, DOI 10.1039/B715458E, cited by 0019
36 Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new
scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry
31(2):455–461, DOI 10.1002/jcc.21334, cited by 0949
37 Wheate NJ, Taleb RI, Krause-Heuer AM, Cook RL, Wang S, Higgins VJ, Aldrich-Wright JR (2007)
Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehi-
cles. Dalton Transactions (43):5055–5064, DOI 10.1039/B704973K, 00055
38 Zhai Q, Gao C, Ding J, Zhang Y, Islam B, Lan W, Hou H, Deng H, Li J, Hu Z, Mohamed HI, Xu S, Cao
C, Haider SM, Wei D (2019) Selective recognition of c-MYC Pu22 G-quadruplex by a fluorescent
probe. Nucleic Acids Research 47(5):2190–2204, DOI 10.1093/nar/gkz059
Chapter 4
SOMSpec: a machine learning
approach to protein secondary
structure prediction from Infrared
and Circular Dichroism spectra
Figure 4.1: SOMSpec logo.
During my time at Warwick University, in addition to designing and performing
molecular dynamics simulations, there was a request to redesign some existing
inhouse software for protein secondary structure prediction from circular dichroism
(CD) spectra. The existing program, named SSNN,20 was written a couple of years
before by a student of the group. The program was specific to CD data, was slow
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(requiring multiple hours to train), required data to be in a very strict format
and lacked any way to add additional features, such as support for variable step
sizes, or plotting of melt curves. As I had amassed a large number of CD and
SRCD spectra comprising various DNA motifs, I also saw the potential in predicting
secondary structure of nucleic acids. There was the additional desire for improved
flexible and potentially enable prediction from IR and RAMAN spectra. As a result,
I wrote SOMSpec. Over time SOMSpec has evolved into a fully fledged software
suite able to be trained on any type of spectral data, and predict any number of
properties provided an appropriate validated training set exists. It can be operated
either by command line or graphical interfaces. SOMSpec features various modules
for pre- and post- data formatting. The implementation details are included in
the manuscript and an installer for Linux or Windows can be downloaded from
somspec.org. It is free software licensed under GPLv3. The architecture of SOMSpec
is outlined in the flowchart in Figure 4.2.
Following is a brief description of how SOMSpec operates. The implementation
specifics are described in the manuscript. Consider a single CD spectrum of a
protein. By stripping the wavelength data from this it becomes a simple one
dimensional vector of values, with each value representing a given magnitude
for each step along the wavelength range. If enough of these vectors are placed
in a grid, oriented along the z axis, and a machine learning algorithm allowed
to recursively operate on and change these vectors, or nodes, an interesting
emergent property is exhibited. The nodes, each representing a single spectrum, are
topologically grouped by features. This is the basis for what are known as Kohonen
self organising maps (SOM).21 A pictorial representation of a self organising map
is presented as Fig. 1 in the manuscript. What is important to note is that each
node represents an arbitrarily large vector and is equally spaced across a cartesian
addressable grid. If each node was summed and plotted as a 3D surface or heat
map it would look like Figures 4.3 and 4.4, respectively.
In Figure 4.4 the topological grouping of secondary structure properties is
readily apparent. The midpoints and vector sum plots are simplistic representations
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Figure 4.2: Flowchart of how the main SOMSpec program operates. The two main
decision trees are TRAIN, where a map is created from the training set, and TEST,
where a trained map is used to make predictions from a user provided spectrum.
of the midpoint value and sum of each vector, respectively. The Property 1–5 plots
represent the distribution of α-helix, β-sheet, bends, turns and other secondary
structure content of the trained map. It is evident how nodes containing significant
Property 1 (α-helix) are arranged topologically away from those containing high
Property 2 (β-sheet), as is expected. Property 6 indicates the locations of each
training set spectrum within the map (yellow squares).
A useful feature of the representation in Figure 4.4 is the ability to quickly
analyse a training set for deficiencies or odd spectra. An example in this case is
node (14,22) of the Property 1 plot (dark blue square upper centre). This node
is part of the training set, as can be confirmed by checking the Property 6 plot,
and stands out for not containing the same percentage α-helix secondary structure
as the surrounding nodes. This indicates the spectrum is either of poor quality or
possesses incorrectly annotated secondary structure information.
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Figure 4.3: 3D surface plot of a 40 × 40 node self organising map trained on 47
protein training set of infrared spectra. The values for each node are summed and
presented as a single value.
Figure 4.4: Various plots of a 30 × 30 node self organising map displaying the
emergent topological grouping of information. The plots labelled Property 1–5
represent the total α-helix, β-sheet, bends, turns and other secondary structure
content of each node on the trained map. The SOM was trained on 47 transmission
infrared protein spectra annotated with five secondary structure properties.
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SOMSpec utilises this emergent property of self organising maps. It reads in a
set of spectra with known structure properties—the training set—and generates a
map which can be used to match with experimental spectra and therefore make
predictions on the properties of that spectra. Clearly, the choice of algorithms
and data format is key to the success of this method. Significant code review and
validation testing has so far been performed, and although there are a number of
variables which may be chosen when training, many are interdependent and are
automatically calculated in this implementation. The user only needs to decide on
the map size, how many properties to predict (which is ultimately predicated on the
quality of the training set) and number of iterations. Extensive validation testing
at map sizes between 10–100 and iterations between 10,000–100,000 has so far
revealed the root mean square deviation (RMSD) in predictions varies less than
10%. This is in part due to the robust design and scaling of the SOMSpec code, so
that in practice there is little change in the accuracy of the results when varying the
map size or number of iterations in the training process.
A suitable training set consists of multiple spectra with annotated structure
properties. Initial development used an existing CD training set of 47 proteins
annotated with five secondary structure properties: α-helix, β-sheet, turns, bends,
and other.20 Subsequent development utilised the globular protein SP175 dataset,
comprising 71 globular protein CD spectra from 175–240 nm. This reference set is
considered the gold standard, and is published on the Protein Circular Dichroism
Data Bank (PCDDB).22 The standard PCDDB annotations are from DSSP.23 These
properties were combined into the five standard classes as follows: helix (H+I+G),
sheet (B+E), bonded turn (T), bend (S), loop or irregular (C). A curated training
set of various double-stranded and G-quadruplex DNA sequences is currently in
progress but should provide the ability to somewhat predict DNA structure, or at the
very least discriminate between parallel and anti-parallel G-quadruplex topologies.
When choosing a training set it is important to validate suitability, specifically
the informational content of the set. SOMSpec incorporates an automated leave-
one-out-validation process (LOOV) for this purpose. The process involves removing
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Figure 4.5: Scatter plots depicting the root mean square deviation of predicted
secondary structure properties of the SP175 training set at map sizes of 20×20–
70×70 and 20,000 (red) and 60,000 (blue) iterations.
one spectrum from the training set, training on the remaining set, then predicting
the properties of the removed spectrum, and finally, comparing the predicted results
with the sets own annotation values. The validation results of the SP175 data set
at two epoch levels and a range of map sizes and are presented in Figure 4.5.
Each data point represents one protein spectrum from the set, with RMSD of the
predicted vs real properties plotted. The majority of points are clustered between
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0.0–0.1 RMSD. It is difficult to graphically represent such multidimensional data
but this representation is useful to compare the effects of varying map sizes
and iterations. It also allows the identification of proteins with potentially poor
annotations.
Choice of the IR training set was guided by best practice. Specifically, the 1600–
1700 cm−1 region was chosen, corresponding to the protein Amide I band. It
is well understood that the exact band maximum is determined by the hydrogen
bonding and backbone conformation of the protein, hence it contains much of the
secondary structure information of a protein. This region also exhibits the most
intense absorption in a protein IR spectrum. All spectra were normalised to create
the training set.
A draft of the manuscript follows. This document outlines the underlying
machine learning theory, based on Kohonen maps.21 As the primary author, I
designed and developed all software, artwork and graphics and wrote all of the
text, excluding the transmission IR and RAMAN training set acquisition which
was performed by Marco Pinto-Corujo (University of Warwick). I also designed,
developed and host the associated website somspec.org where the software will
be distribute in binary and source code formats along with training sets where
available with source code hosted on Gitlab. An important planned feature includes
the prediction of CD spectra given a PDB structure, or simply secondary structure
content, which would be implemented as a reversal lookup of a trained map. This
work will be submitted to the RSC journal PCCP in the near future.
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SOMSpec: a machine learning approach to protein
secondary structure prediction from Infrared and Cir-
cular Dichroism spectra
Dale L. Ang,∗a Marco Pinto-Corujo,b‡ Nikola Chmel,b‡ Alison Rodgerc and Janice
Aldrich-Wrighta
Protein secondary structure prediction is achievable from infra red (IR) spectra (transmission and
Raman) using a machine learning algorithm based on self organising maps. We show that this
method can predict protein secondary structures information from IR data within <5%. With ap-
propriate training sets, SOMSpec can be directly used for a wide range of other applications. We
show that our approach and our implementation of it is flexible enough to accept non-spectral
data such as the Iris flower data set as well as undertake secondary structure fitting from circular
dichroism spectra. We anticipate direct application to structure prediction using other spectro-
scopic techniques such as Raman and Raman Optical activity and to other macromolecules such
as DNA when high quality training sets that cover the structural space become available. Two two
high quality reference sets of protein spectra - set of 47 transmission IR spectra and 46 RAMAN
spectra have also been acquired and are provided with this software as robust training sets. Appli-
cations range from fast protein structure prediction to antibody testing, forensics and other fields.
The software is licensed under GPL3 and we encourage contribution from other researchers.
Introduction
Interpretation of data obtained via spectroscopic techniques such
as infrared (IR) and circular dichroism (CD) spectroscopy, is of
great importance to industrial and pharmacological research, par-
ticularly in quantifying the secondary structure (SS) content of
biomolecules such as proteins and nucleic acids. Specifically,
applications include drug design, and biopharmaceutical qual-
ity control due to the inherent structure-function relationships of
biomolecules. The human genome is estimated to contain around
21,000 protein-encoding genes while the total number of proteins
in human cells is estimated to be upwards of 250,000. Currently,
the protein data bank contains structures for approximately 10%
(~28,000)1 of these proteins with most of the structures being
crystallographic so not necessarily representative of solution be-
a Nanoscale Organisation and Dynamics Group, Western Sydney University, Campbell-
town, NSW, 2560, Australia.
b Department of Chemistry, University of Warwick, Coventry, CV4 7AL, United King-
dom.
c Molecular Sciences, Macquarie University, NSW, 2109, Australia.
† Electronic Supplementary Information (ESI) available: training data sets and
validation results. Source-code and precompiled binaries for Linux and Win-
dows are available for download from https://www.somspec.org. See DOI:
10.1039/b000000x/
haviour. Given this, there is a significant deficiency in the struc-
tural knowledge for a vast array of proteins and environments.
The two most common methods of obtaining protein structure,
XRD and NMR, have a number of drawbacks making them un-
suitable for many proteins. X-ray diffraction requires crystals of
sufficient quality which often very difficult to obtain, and NMR
requires high quantities of stable protein for the extended time
scales required of the experiments. These techniques are also
limited in terms of concentration and environment. The circu-
lar dichroism spectrum of a protein, while not giving an atomic
resolution structure, can often be analysed to provide reasonable
estimates of secondary structure content of that protein as long
as the concentration is between 0.01 mg/mL and 10 mg/mL and
the buffer components do not absorb much light down to 190
nm. A variety of computational methods exist to tease out rea-
sonable estimates of the SS content from CD spectra including
SELCON3, CONTIN, CDsstr and our own SSNN (secondary struc-
ture neural network).2 Other neural network approaches such as
K2d3 and SOMCD4 might be as successful but are only available
as pretrained programs with dated and limited reference sets.
We recently turned to infrared spectroscopy to cope with sam-
ples with significantly absorbing buffer components or concentra-
tions above 10 mg/mL and were surprised to find a lack of robust
validated methods to extract SS despite many people using it for
the purpose. Most approaches that are used involve curve fitting
to the spectrum or its second derivative and assigning each re-
sulting Gaussian or Lorenzian to a secondary structure motif. It
logically seemed to us that an approach analogous to those used
with CD data ought to be preferable. However, this requires both
a good reference set of spectra covering the structural space and
a methodology to extract SS.
In this paper we present SOMSpec, the results of our effort
to improve our previous algorithm SSNN2 to encompass infrared
protein spectra and indeed to almost anything else where the ref-
erence training set and test data (such as an IR or CD spectrum)
is associated with structural (or other descriptor) data. SOMSpec
incorporates a suite of programs for automating the entire pro-
cess of training and prediction and validation tools for training set
development. SOMSpec is currently implemented as Matlab com-
patible code making a reproducible, robust and reliable approach
to protein secondary structure analysis from infrared absorbance
data. Our approach was to provide a classical SOM-based tool for
the classification and property prediction of any range of inputs,
with a focus on protein secondary structure from spectral data.
Our previous implementation focused solely on predicting the SS
of a protein from its CD spectrum with predetermined un-flexible
parameterisation. Our goal here was to provide a tool that was
directly applicable to other spectral, with immediate emphasis on
IR absorbance but allowing for more generalised inputs. We have
therefore generalised the approach and improved the algorithms
used.
The program suite.
SOMSpec can be run either through a graphical user interface
(GUI) or from a terminal. The terminal version is currently the
more flexible and the only way to access some of the more ad-
vanced features. Several of the main programs are briefly de-
scribed.
Features of the main SOMSpec application include:
• All input file formats for training and predicting are column
based plaintext comma, tab or space separated. Number of
columns and rows is arbitrary. Each column represents a
single spectrum and the software automatically determines
the number of columns and field separator at runtime.
• Input formats are internally interpolated so there is no need
to match steps as long as wavelength domain is the same
• Number of properties is flexible, from 1 to many but in prac-
tice <6.
• Visualisation options: realtime graphical representation of
map training and completed maps, interpolated spectra, all
switchable at runtime. The realtime visualising of the map
training is great for teaching/understanding SOM concepts
and how training/learning works. Also useful for debugging.
• Automated leave-one-out-validation (LOOV). This means it
automatically processes a training set and trains, then tests.
• Scaling of input spectra. this is especially useful for CD as
alpha content affects magnitude
Additional tools included with the SOMSpec suite:
• automatically build training sets from PCDDB data, evaluate
melts with plotting of SS vs Temp, generation of SELCON
input files for validation against existing toolkits/software
• GUI access to most tools (common) from Windows/Linux
executable
Program descriptions.
The following is a list of programs comprising the SOMSpec suite.
SOMSpec.m: Command-line version of the main program and
the most fully featured version. Ability to controlling all train-
ing/predicting and validation operations. Additional features in-
clude the ability to observe the training in real time, automatic
concentration/normalisation of spectra, support for any number
of discrete property features, and several other more advanced
features. Useful for running on headless servers and remote com-
puters.
SOMSpecGUI.m: Graphical interface version of the main pro-
gram. Limited in features compared to the command-line version
but provides the most commonly used features such as training,
prediction, plotting of trained self-organising maps, and valida-
tion.
SSJAS.m: Produces correctly formatted SELCON input files
from Jasco ascii files. Useful for testing and comparing results
between SOMSpec and SELCON. Input is 1 CD spectrum.
SSJASMULTI.m: Produces correctly formatted SELCON input
files from Jasco ascii files. Useful for testing and comparing re-
sults between SOMSpec and SELCON. Ability to process multiple
spectra at once. Input is a directory of CD spectra. Data must be
formatted from long to short wavelength, ie. 240 - 190 nm and
span the required training sets.
SSJCDProc.m: Reads and processes standard Jasco Spectra
Manager output files. Flexible enough to accept any version.
Provides automatic translation from Jasco format to SELCON or
SOMSpec input.
SSPCDDB.m: Produces correctly formatted training sets from
PCDDB .pcd files. Input is a directory of CD spectra. Data MUST
be formatted from long to short wavelength, ie. 240 - 190 nm
and span the required training sets.
SSPLFIT.m: Plot the results of multiple spectral predictions,
fit sigmoidal curves and output values. Extremely useful for pro-
cessing CD melts.
SSPLOT.m: Plots the results from a multi-file processing. See
SSPLFIT.m.
SSSOMPLOT.m: Reads in a trained SOM and plot the results.
Similar output to the real-time plots option but accessible after a
run. Also accessible from the GUI.
SSVALIDATE.m: Automated Leave-One-Out-Validation
(LOOV) program for SOMSpec. Creates properly formatted
training set and input files that allow iteration through a training
set.
Implementation
Self-organising map and protein secondary structure predic-
tion.
A self-organising map (SOM),5 is a type of artificial neural net-
work that can be trained in an unsupervised manner. Unsuper-
vised learning is where unclassified data (in our case the spec-
trum of a protein, nucleic acid, and so on) is sorted by identifying
commonalities.
To predict the secondary structure content of a protein given it’s
CD spectrum our implementation takes several steps. 1) training
a SOM from a reference set, 2) using that SOM as the basis of
predicting the SS content from a "test" spectrum. Pictorially, our
SOM is represented in figure 1. In practice each step is compli-
cated by many factors.
A SOM achieves this first by organising a reference set into a 2
dimensional map (training)–the distance between nodes reflect-
ing how different the data sets are. The missing nodes are filled by
creating weighted averages of the reference set nodes. All nodes
are then assigned SS properties matching as closely as possible.
The result is a topologically ordered map which mimics the input
training set with regions corresponding to particular features of
the input space. The prediction step involves finding the most
closely representative nodes to the given test spectrum and calcu-
lating the secondary structure as a weighted sum of those nodes
as output.
Fig. 1 Pictorial representation of a self-organising map.
The three phases.
Training occurs in two phases. Phase 1: map construction, and
Phase 2: structure assignment. Phase 3 can be considered the
prediction of properties given a test spectrum.
Phase 1: map construction. Phase 1 begins with the initialisa-
tion of an untrained randomised map. The reference set (input
vector space), consisting of columns representing each spectrum,
is randomly sampled a user-definable number of iterations. For
each iteration a single node of the map is identified as the best
matching unit (BMU) of the input vector under consideration cal-
culated as the Euclidean distance between the node vector and







where Ii and Wi are the current input (reference set member)
and node vectors respectively, and n is the number of values in
the vector. All other nodes within the current neighbourhood of
the BMU are influenced according to equation 2
W (t +1) =W (t)+θ(t)L(t)(I(t)−W (t)) (2)
Here, t is the current time step/iteration, θ(t) is the radial
bias function (responsible for the spatial convolution of the xxx)
(equation 3) which is the region of influence of the current learn-
ing step, also known as the neighbourhood, L is the learning rate.
Setting the BMU as the active node, all other map nodes within
the neighbourhood are biased in a distance dependent manner
using the radial biasing function
θ(t) = exp




The radius value initialises at half the map size. Values for both
the radius and learning rates decay exponentially following the
general equation:





where Z represents the radius or learning rate. An important
aspect of this decay function is its reliance on the time constant, c.
The time constant is calculated automatically according to equa-
tion 5.
c =
Number o f iterations
ln(radius)
(5)
Once the total number of iterations is reached Phase 2 com-
mences.
Phase 2: assigning SS content to nodes. In Phase 2 begins
the input space (training set) is sequentially sampled and a best
matching node or unit (BMU) is identified for each input vector
according to a NRMSD calculation (equation 6). This node is then
assigned structural parameters accordingly. Surrounding nodes
are assigned structural parameters accordingly.
Once the input space is exhausted, training is complete. Var-
ious plots of the trained map and each property are displayed
for convenience and as a visual check that the training com-
pleted successfully (see ESI). The map weighting and property
data along with a parameters file containing the map details such
as learning rate, map size, number of iterations, and time con-
stant is output as plain comma separated text files. Realtime visu-
alisation is a useful feature which, when enabled, assists the user
to understand the processes involved in SOM training.
Phase 3: predicting SS content from spectra. A user definable
number of BMUs may be specified (default is 5) and are ranked
according to similarity to the input vector. Once the desired num-
ber of BMUs is found, the property contribution of each BMU
to the final node value is calculated using a distance dependent
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weighting.
Prediction of unknown properties for a test data set (in our case
a measured spectrum from which we wish to determine protein
SS), follows in a similar way to the property assignment train-
ing. The only current caveat, apart from issues of data quality,
is that the row (spectral) dimension of the test set must match
the training set used. Any number of columns can be present and
is automatically calculated at run time. Tests are run iteratively
against each SOM node to identify a user-definable number of
BMUs for each input test item. These BMUs are ranked by simi-
larity to the input and the contribution of each is calculated in a
distance dependent manner following equation (1.3). In the fi-
nal step the results are normalised and assigned as the property
prediction. Estimation of spectra is performed by interpolating
across the BMUs and is visualised in the output along with a two
dimensional representation of the SOM with BMUs present (as
illustrated in Figure 2). The predicted spectral NRMSD value is






Figure 2 BMU positions and predicted spectrum output after a
prediction The top BMUs contributing to the property prediction
are labelled displayed. The predicted spectrum (blue) overlays
the input spectrum (black) along with residuals (red).
It should be noted that in this implementation the only neces-
sary user defined options are the map size and number of itera-
tions. All other parameters are calculated from these at runtime.
For research and testing purposes the code is readily reconfig-
urable with respect to other parameters such as the number of
BMUs and the size of the map; additional biasing functions are
present in the code to be implemented if desired. Recommenda-
tions on approximate values for various data sizes can be found
in the ESI.
Results and discussion.
Leave one out validation.
The SOMSpec code was validated using a leave-one-out protocol.
(note here that the results are not directly comparable to previ-
ous code as the NRMSD is calculated differently). Comparisons
with respect to our previous code from CD fitting data shows that
SOMSpec more consistently predicts more accurately that SSNN.
IR data set.
A primary driving force for the development of SOMSpec was the
ability to predict protein SS content from IR spectra. Such an ap-
proach has only recently become possible due to the availability of
a high quality (47 protein) reference set collected on 10 mg mL−1
protein solutions in a CaF2 cell collected at 2 cm
−1 resolution.
Following literature precedent we normalised the spectra to
have maximum magnitude of 1 between 1600 and 1700 cm−1
and considered only the data in this range. A leave-one-out-
validation validation (LOOV) was performed on this data set for
a variety of map sizes and iterations. Complete results are pro-
vided in Table 1 of the ESI. It was found that for this size dataset
(46 proteins) with this level of information content (6 structure
motifs) a map size of 40×40 with 40,000 iterations gave the best
trade-off between training time and accuracy of results in terms
of final NRMSD values.
Current limitations
The application is single threaded. Training a large map only
takes a few minutes on a recent processor (eg. Intel Core i5-
8250U). Predictions only take less than two seconds. The code
has been validated to very large maps (80×80) and a high num-
ber of iterations (100,000). There is no technical reason (other
than memory usage) why it couldn’t be extended to further as the
code supports arbitrary sizes.
Conclusions
We have developed a software package for the prediction of pro-
tein SS from IR spectra. The method is flexible enough that var-
ious other spectrophotometric or other classification data may
be fed in and property predictions obtained as, internally, the
code does not differentiate between protein structure or any other
property. SOMSpec aims to be an easy to use program for train-
ing neutral networks tailored towards the spectroscopist. There
are several useful modules with more in the planning and imple-
mentation stage as the needs arise. SOMSpec was developed to
scratch an itch in our own research and has quickly been adopted
by as a rapid and easy to use tool for secondary structure pre-
diction and it is hoped will be similarly adopted to the wider sci-
entific community. Work has already begun on further reference
training sets and in the future it is envisaged that Raman and any
other spectroscopic techniques will be exploited for their property
prediction using this tool. The SOMSpec code is currently com-
patible with any platform supporting recent versions of Matlab
(tested on Matlab 2018).
Methods.
Protein samples
A set of 33 Lyophilised protein powders from Sigma Aldrich for
solid state infrared and a different set of 32 for Raman prepared
as described next.
Transmission infrared sample preparation and instrumenta-
tion
Between 1 and 5 mg of the protein powder was first grounded in
a mortar and after mixed with also ground KBr (s) to obtain a 1 to
10% dilution. Next, the KBr and protein mixture was compressed
by means of a hydraulic press between 5 and 10 kpsi for 1 min
and a pellet was obtained. NaCl windows in a PIKE Technologies
cell were used to hold the pellet in the way of the beam.
The measurements were carried out with a Jasco FT/IR-4200
spectrometer with a 4 cm−1 resolution, cosine apodization, TGS
detector and accumulated over 100 scans in the range between
400–4000 cm−1. A 10 L min−1 flow rate N2(g) was used to purge
the instrument from water vapour: the interferometer first un-
til the level of water vapour reached a minimum then only the
sample chamber during the measurements.
A water spectrum was collected separately with CaF2 windows
was subtracted using the small water band in the region between
1800–2400 cm−1 as a reference.
Raman sample preparation and instrumentation
Between 5 and 10 mg of the protein powder was first ground
in a mortar and then introduce in a 4×4 mm Starna quartz cu-
vette for the measurement. The instrument used was a Thermo
Scientific DXR SmartRaman spectrometer with a charge coupled
device (CCD) camera and a continuous wave (CW) laser of 633
nm excitation wavelength and 6–8 mW output power. Due to
extreme background fluorescence, some proteins were externally
photobleached with a homemade photobleaching unit consisting
of CW diode lasers of 532 and 635 nm excitation wavelength and
200 mW output power previous to the measurement. The num-
ber of accumulations ranged from 1000–9999 depending on the
amount of fluorescence found and the spectral region from 50–
3500 cm−1.
Although the smart background option was selected, a fur-
ther background subtraction was performed to eliminate arte-
facts in some regions of the spectrum for which an empty cuvette
spectrum was previously collected. Moreover, a cubic spline fit
method was applied to baseline the spectra and after scaled by
the interval method.
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Chapter 5
Other outputs
This chapter highlights additional research that was not the major focus of my
PhD but where my contributions were sought from collaborators. These include
published articles, journal covers, conference abstracts, posters, and grants and
scholarships received. All are presented in chronological order with most recent
first and are accompanied by an explanation of relevance to my main research.
5.1 Additional refereed articles
The following is a list of additional published papers that I have co-authored
during my PhD as part of ongoing research undertaken within my research
group and broader collaborators. The paper reference, abstract, impact and my
contribution are provided. Citations were obtained from Google Scholar and are
current as of 20 November 2019.
Paper 1 - Review: Deo, K. M.; Ang, D. L.; Gordon, C. P.; Aldrich-Wright, J. (Nov
2018). Platinum coordination compounds with potent anticancer activity.
Coordination Chemistry Reviews. DOI: 10.1016/j.ccr.2017.11.014. (Journal
Impact Factor: 14.499, Citations = 29).24
Abstract: Many international researchers have strived to understand the mecha-
nism of action or improve the efficacy of inorganic coordination compounds
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that have been identified to exhibit anticancer activity. The inherent chal-
lenges of chemotherapy demand that new strategies be developed utilising
different mechanisms of action to interrupt the cellular machinery of cancer
cells. In Australia, we have benefited from the research of colleagues
who have influenced modern platinum chemistry by contributing to our
understanding of platinum oxidation and reduction, the mechanism of action
of cisplatin, and unique design strategies for new platinum complexes. The
purpose of this review is to provide some background in the history and
development of platinum(II) and platinum(IV) complexes.
Impact: Research for this review provided a way for me to keep abreast of the
current research on this important category of biologically active compounds.
The recent advances in platinum(IV) complexes yields an interesting and
functionally convenient way to design these complexes with additional
payloads and opens many new avenues to making more selective and effective
compounds.
Contribution: All figures and illustrations, significant writing, and final editing.
Paper 2 - Original research: Pinto-Corujo, M.; Sklepari, M.; Ang, D. L.; Millichip,
M.; Reason, A.; Goodchild, S. C.; Wormell, P.; Amarasinghe, D. P.; Lindo,
V.; Chmel, N. P.; Rodger, A. (Aug 2018). Infrared absorbance spectroscopy
of aqueous proteins: comparison of transmission and ATR data collection and
analysis for secondary structure fitting. Chirality. DOI: 10.1002/chir.23002.
(IF: 1.833, Citations = 1).25
Abstract: Attenuated total reflectance (ATR) infrared absorbance spectroscopy of
proteins in aqueous solution is much easier to perform than transmission
spectroscopy, where short path-length cells need to be assembled repro-
ducibly. However, the shape of the resulting ATR infrared spectrum varies
with the refractive index of the sample and the instrument configuration.
Refractive index in turn depends on the absorbance of the sample. In this
work, it is shown that a room temperature triglycine sulfate detector and
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a ZnSe ATR unit can be used to collect reproducible spectra of proteins. A
simple method for transforming the protein ATR spectrum into the shape of
the transmission spectrum is also given, which proceeds by approximating
a Kramers-Krönig–determined refractive index of water as a sum of four
linear components across the amide I and II regions. The light intensity at
the crystal surface (with 45◦ incidence) and its rate of decay away from the
surface is determined as a function of the wave number–dependent refractive
index as well as the decay of the evanescent wave from the surface. The
result is a single correction factor at each wave number. The spectra were
normalized to a maximum of 1 between 1600 cm−1 and 1700 cm−1 and a
self-organizing map secondary structure fitting algorithm, SOMSpec, applied
using the BioTools reference set. The resulting secondary structure estimates
are encouraging for the future of ATR spectroscopy for biopharmaceutical
characterization and quality control applications.
Impact: Machine learning techniques are entirely dependent on high quality
training sets, and SOMSpec is no different. Given that there is a dearth of
quality IR spectral training sets of proteins we set out to satiate this need and
provide a useful, and freely available, training set for such an application.
Transmission IR is a convenient way of obtaining a spectrum but is limiting
in several ways including path length, solubility of the analyte of interest,
and other factors. Attenuated Total Reflectance (ATR) IR spectroscopy is a
related technique that alleviates some of the problems, but at the cost that
the spectrum is slightly different to a transmission IR spectrum. This paper
set out to compare and contrast these differences. A future paper, soon to be
published, actually deals with the theoretical aspects of converting an ATR IR
spectrum to a transmission spectrum.
Contribution: Wrote all code and processed spectra (see SOMSpec, Chapter 4),
minor writing.
Paper 3 - Original research: Šmidlehner, T.; Kurutos , A.; Slade, J.; Belužić, R.;
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Ang, D. L.; Rodger, A.; Piantanida, I. (Feb 2018). Versatile cyanine-click-
amino acid conjugates showing one-atom-influenced recognition of DNA/RNA
secondary structure and mitochondrial localization in living cells. European
Journal of Organic Chemistry. DOI: 10.1002/ejoc.201701765. (IF: 2.834,
Citations = 5).26
Abstract: By a simple click CuAAC (copper(I)-catalysed azide alkyne cycloaddi-
tion) procedure several cyanine dye analogues have been attached to the
side-chain of an amino acid to yield chromophore amino acid conjugates with
the potential to fluoresce upon binding to a target. Due to the availabiltiy
of the amino acid C and N termini for peptide coupling, these conjugates
are suitable for easy incorporation into the backbone of peptides. The novel
amino acid dyes prepared in this work, although intrinsically non-fluorescent,
gave rise to strong fluorimetric responses upon binding to double-stranded
(ds) DNA or RNA, the emission response to various polynucleotide secondary
structures being controlled either by linker length or a halogen atom located
on the cyanine part of the molecule. Molecular modelling confirmed the
mode of binding to different polynucleotides, which was responsible for the
recognition. Interestingly, cell localisation experiments showed that the dyes
were specifically localised in mitochondria at variance with the localisation
of the parent dyes, which accumulate in cell nuclei, which suggests that
the amino acid tail (containing a triazole ring) might function as a novel
mitochondria-directing appendage.
Impact: The specific DNA interactions these compounds underwent was visualised
using molecular dynamics simulations. Additionally, the aggregation be-
haviour was simulated to determine the primary form of aggregate, being
a H-type head-to-tail aggregate.
Contribution: Molecular dynamics simulations and analysis of the molecule with
DNA including generation of final illustrations, and significant writing of
computational components. Assistance with spectroscopic experiments.
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Paper 4 - Review: Bjelosevic, A.; Pages, B. J.; Spare, L. K.; Deo, K. M.; Ang, D.
L.; Aldrich-Wright, J. R.. (Jan 2018). Exposing “bright” metals: promising
advances in photoactivated anticancer transition metal complexes. Current
Medicinal Chemistry. DOI: 10.2174/0929867324666170530085123. (IF:
3.249, Citations = 6).27
Abstract: Photodynamic therapy (PDT) is an increasingly prominent field in anti-
cancer research. PDT agents are typically nontoxic in the absence of light and
can be stimulated with nonionising irradiation to “activate” their cytotoxic
effect. Photosensitzers are not classified as chemotherapy drugs although it
is advantageous to control the toxicity of a drug through localised irradiation
allowing for selective treatment. Transition metals are an extremely versatile
class of compounds with various unique properties such as oxidation state,
coordination number, redox potential and molecular geometry that can be
tailored for specific uses. This makes them excellent PDT candidates as their
properties can be manipulated to absorb a specific range of light wavelengths,
cross cellular membranes or target specific sites in vitro. This article reviews
recent advances in transition metal PDT agents, with a focus on structural
scaffolds from which several metal complexes in a series are synthesised, as
well as their in vitro cytotoxicity in the presence or absence of irradiation.
Impact: As the title suggests, this review focussed on photoactivated anticancer
metal complexes. This is a dynamic and innovative area of research that
provides some context on other areas of metals research.
Contribution: All authors contributed equally to the writing and editing where
each section of the document was allocated to a different author. Additional
contributions by me included final editing and reviewing of the document.
Paper 5 - Review: Rodger, A.; Dorrington, G.; Ang, D. L., (Nov 2016). Linear
dichroism as a probe of molecular structure and interactions. Analyst. DOI:
10.1039/C6AN01771A. (IF: 4.107, Citations = 9).28
Abstract: Linear dichroism (LD) spectroscopy involves measuring the wavelength
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(or energy) dependence of the difference in absorption of light parallel and
perpendicular to an orientation direction. It requires samples to have a
net orientation. The aim of this review is to summarise some UV–visible
linear dichroism (LD) methods that can be usefully applied to increase our
understanding of biomacromolecules and their complexes that have a high
aspect ratio. LD shares the advantages of most spectroscopic techniques
including the fact that data collection is fairly straightforward and many
sample types can be investigated. Conversely, LD shares the disadvantage
that the measured signal is an average over all species in the sample on
which the light beam is incident. LD mitigates this disadvantage somewhat
in that only species which are oriented give a net signal. How the data
can be analysed to give structural information about small molecules in
stretched films and membrane systems or bound to biomacromolecules and
directly about biomacromolecules such as DNA and protein fibres forms part
of this review. In the UV-visible region LD often suffers noticeably from light
scattering since the samples tend to be large relative to the wavelength of
the incident light, so consideration is also given to data analysis challenges
including removal of scattering contributions to an observed signal. Brief
mention is made of fluorescence detected LD.
Impact: Somewhat like circular dichroism, linear dichroism is often applied to the
analysis of small molecule binding. The speciality of linear dichroism is that
it can observe orientable molecules, those comprised of long chain, such as
DNA. This review was important to summarise and provide some background
context on the theory and applications of linear dichroism.
Contribution: Writing and significant editing, along with generation of illustra-
tions.
Paper 6 - Review: Deo, K. M.; Pages, B. J.; Ang, D. L.; Gordon, C. P.;
Aldrich-Wright, J. (Oct 2016). Transition Metal Intercalators as Anticancer
Agents—Recent Advances. International Journal of Molecular Sciences.
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DOI:10.3390/ijms17111818. (IF: 3.687, Citations = 37).29
Abstract: The diverse anticancer utility of cisplatin has stimulated significant
interest in the development of additional platinum-based therapies, resulting
in several analogues receiving clinical approval worldwide. However, due to
structural and mechanistic similarities, the effectiveness of platinum-based
therapies is countered by severe side-effects, narrow spectrum of activity
and the development of resistance. Nonetheless, metal complexes offer
unique characteristics and exceptional versatility, with the ability to alter their
pharmacology through facile modifications of geometry and coordination
number. This has prompted the search for metal-based complexes with
distinctly different structural motifs and non-covalent modes of binding with
a primary aim of circumventing current clinical limitations. This review
discusses recent advances in platinum and other transition metal-based
complexes with mechanisms of action involving intercalation. This mode of
DNA binding is distinct from cisplatin and its derivatives. The metals focused
on in this review include Pt, Ru and Cu along with examples of Au, Ni, Zn
and Fe complexes; these complexes are capable of DNA intercalation and are
highly biologically active.
Impact: This review focussed on the larger family of anticancer metal complexes.
In addition to platinum we also reviewed recent advances in ruthenium,
copper, gold, nickel, zinc and iron complexes.
Contribution: All authors contributed equally to the writing where each was
allocated a range of metals to review. I was also involved with the creation of
all figures and illustrations, and final editing.
Paper 7 - Original research: Pages, B. J.; Sakoff, J.; Gilbert, J.; Rodger, A.; Chmel,
N. P.; Jones, N. C.; Kelly, S. M.; Ang, D. L.; Aldrich-Wright, J. R. (May
2016). Multifaceted Studies of the DNA Interactions and In Vitro Cytotoxicity
of Anticancer Polyaromatic Platinum(II) Complexes, Chemistry A European
Journal. DOI: 10.1002/chem.201601221. (IF = 5.731, Citations = 14).30
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Abstract: This study reports a detailed biophysical analysis of the DNA bind-
ing and cytotoxicity of six platinum complexes (PCs). They are of the
type [Pt(PL)(SS-dach)]Cl2, where PL is a polyaromatic ligand and SS-
dach is 1S,2S-diaminocyclohexane. The DNA binding of these complexes
was investigated using six techniques including ultraviolet and fluorescence
spectroscopy, linear dichroism, synchrotron radiation circular dichroism,
isothermal titration calorimetry and mass spectrometry. This portfolio of
techniques has not been extensively used to study the interactions of such
complexes previously; each assay provided unique insight. The in vitro
cytotoxicity of these compounds was studied in ten cell lines and compared to
the effects of their R,R enantiomers; activity was very high in Du145 and SJ-
G2 cells, with some submicromolar IC50 values. In terms of both DNA affinity
and cytotoxicity, complexes of 5,6-dimethyl-1,10-phenanthroline and 2,2′-
bipyridine exhibited the greatest and least activity, respectively, suggesting
that there is some correlation between DNA binding and cytotoxicity.
Impact: These platinum complexes are a variation on the usual structure investiga-
tion and were important to assess. Some of these complexes have formed the
basis for my own, so far unpublished research on larger aromatic platinum
complexes.
Contribution: Assistance with spectroscopic experiments and interpretation, along
with minor editing.
Paper 8 - Review: Pages, B.; Ang, D. L.; Wright, E.; Aldrich-Wright, J. R., (Oct
2014). Metal Complex Interactions with DNA. Dalton Transactions. DOI:
10.1039/C4DT02700K. (IF: 4.197, Citations = 143).31 Inside cover.
Abstract: Increasing numbers of DNA structures are being revealed using biophys-
ical, spectroscopic and genomic methods. The diversity of transition metal
complexes is also growing, as the unique contributions that transition metals
bring to the overall structure of metal complexes depend on the various
coordination numbers, geometries, physiologically relevant redox potentials,
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as well as kinetic and thermodynamic characteristics. The vast range of
ligands that can be utilised must also be considered. Given this diversity, a
variety of biological interactions is not unexpected. Specifically, interactions
with negatively-charged DNA can arise due to covalent/coordinate or subtle
non-coordinate interactions such as electrostatic attraction, groove binding
and intercalation as well as combinations of all of these modes. The potential
of metal complexes as therapeutic agents is but one aspect of their utility.
Complexes, both new and old, are currently being utilised in conjunction with
spectroscopic and biological techniques to probe the interactions of DNA and
its many structural forms. Here we present a review of metal complex-DNA
interactions in which several binding modes and DNA structural forms are
explored.
Impact: This review was a significant article in so much as it comprehensively
reviewed the existing arena of biologically active metal complexes as can be
attested by the large number of citations.
Contribution: All illustrations, significant editing, minor writing, design of inside
cover.
Paper 9 - Original research: Pages, B.; Li, F.; Wormell, P.; Ang, D. L.; Clegg, J.;
Kepert, C.; Spare, L.; Supawich Danchaiwijit, S.; Aldrich-Wright, J., (Nov
2014). Synthesis and analysis of the anticancer activity of platinum(II)
complexes incorporating dipyridoquinoxaline variants. Dalton Transactions.
DOI: 10.1039/ C4DT02133A. (IF: 4.097, Citations = 24).32
Abstract: Eight platinum(II) complexes with anticancer potential have been syn-
thesised and characterised. These complexes are of the type [Pt(IL)(AL)]2+,
where IL is either dipyrido[3,2-f:2′,3′-h]quinoxaline (dpq) or 2,3-dimethyl-
dpq (23Me2dpq) and AL is one of the R,R or S,S isomers of either 1,2-
diaminocyclohexane (SS-dach or RR-dach) or 1,2-diaminocyclopentane (SS-
dacp or RR-dacp). The CT-DNA binding of these complexes and a series of
other complexes were assessed using fluorescent intercalator displacement
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assays, resulting in unexpected trends in DNA binding affinity. The cytotoxic-
ity of the eight synthesised compounds was determined in the L1210 cell line;
the most cytotoxic of these were [Pt(dpq)(SS-dach)]Cl2 and [Pt(dpq)(RR-
dach)]Cl2, with IC50 values of 0.19 and 0.80 µM, respectively. The X-ray
crystal structure of the complex [Pt(dpq)(SS-dach)](ClO4)2·1.75H2O is also
reported.
Impact: My experience was in synthesising achiral dinuclear platinum(II) terpyri-
dine complexes so this was a departure from my normal protocols and laid
the groundwork for the synthesis of the complexes used in Chapters 1 and 3.




Two of my publications were selected to be published with an accompanying
journal cover in recognition of the significance of the works. These published
artworks, for which I am wholly attributable to the design, are presented in the
following pages.
Cover 1: This artwork was published as an inside cover of RSC Dalton Transactions,
Volume 44, Number 8, Feb 2015, accompanying the article titled "Metal
Complex Interactions with DNA", DOI: 10.1039/C4DT02700K.31
Description: This visually represents the many different interactions of various
metal complexes with a large loop of double stranded DNA. The central image
is a short section of double stranded DNA complexed with cisplatin. The
metal complex:DNA models were sourced from the Protein Data Bank and
generated with UCSF Chimera13 while the long DNA strands were built in
and rendered using Blender.
Cover 2: This was published as the outer back cover of Chemistry–A European
Journal and accompanied the article presented in Chapter 2 titled "Quadru-
plex DNA-Stabilising Dinuclear Platinum(II) Terpyridine Complexes with Flexible
Linkers", DOI: 10.1002/chem.201503663.1
Description: This image represents the binding and stabilisation effects of a
dinuclear platinum complex. The ball and stick central molecule model was
built in and visualised using Avogadro.12 The DNA model was created with
UCSF Chimera.13 Upper left is a QDNA structure, with the accompanying CD
melt spectra in the lower right. The Southern Cross in the lower left corner








Janice R. Aldrich-Wright et al.
Metal complex interactions with DNA  
Volume 44 Number 8 28 February 2015 Pages 3489–3878

5.3 Refereed conference abstracts in conference pro-
ceedings
Abstract 1: Šmidlehner, T.; Kurutos , A.; Slade, J.; Belužić, R.; Ang, D. L.; Rodger,
A.; Piantanida, I. (2017) Fluorophore one-atom-controlled recognition of
DNA/RNA secondary structures. EFMC International Symposium on Advances
in Synthetic and Medicinal Chemistry, August 2017, Vienna, Austria.
Abstract 2: Ang, D. L.; Jones, N. C.; Stootman, F.;Ghadirian, B.; Aldrich-Wright,
J.R. (2015). DNA Binding Studies using Synchrotron Radiation Circular
Dichroism and Mathematica. Proceedings of the Australian Synchrotron User
Meeting, 19th November 2015, Melbourne, Australia.
Abstract 3: Ang, D.L.; Jones, N.; Stootman, F.; Ghadirian, B.; Aldrich-Wright, J.R.
(2015). Improved DNA equilibrium binding affinity determinations of plat-
inum(II) complexes using synchrotron radiation circular dichroism. Pacifichem,
Hawaii, 2015. See Chapter 1.
Abstract 4: Ang, D.L.; Craze, A.; Yuliani, Y.; Kelso, C.; Beck, J.L; Ralph, S.F.;
Harman, D.G.; Aldrich-Wright, J.R. (2015). ESI-MS probing of G-quadruplex
DNA platinum(II) complex interactions. December 2015, Pacifichem, Hawaii.
Abstract 5: Ang, D.L.; Harman, D.G.; Ralph, S.F.; Aldrich-Wright, J.R. (2015).
Quadruplex-DNA stabilising dinuclear platinum(II) complexes. December 2015,
Pacifichem, Hawaii.
Abstract 6: Ang, D. L.; Jones, N. C.; Stootman, F.;Ghadirian, B.; Aldrich-
Wright, J.R. (2015) DNA Binding Studies using Synchrotron Radiation Circular
Dichroism and Mathematica. Proceedings of the Australian Synchrotron User
Meeting, 19th November 2015, Melbourne, Australia.
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5.4 Posters
The following are selected posters most relevant to the work presented in this
thesis. These were presented at various conference throughout the world.
Poster 1: SOMSpec – a machine learning approach to predicting protein secondary
structure from spectra. Ang, D. L.; Rodger, A.; Aldrich-Wright, J. R.. Western
Sydney University HDR showcase, December 2017.
Relevance: This poster presented my work on SOMSpec (Chapter 4) at the annual
WSU Higher Degree Research showcase. It gives a broad overview of what
SOMSpec does, how it’s designed, and a brief overview of the underlying
theory.
Poster 2: Fluorophore one-atom-controlled recognition of DNA/RNA secondary
structure. Šmidlehner, T.; Kurutos, A.; Ang, D. L.; Belužić, R.; Rodger, A.;
Piantanida, I.. Circular Dichroism summer school, Warwick University, UK,
July 2017.
Relevance: This poster presented the results of my work26 on simulating the DNA
interactions of these compounds.
Poster 3: Automated DNA equilibrium binding affinity calculations of platinum(II)
complexes using Synchrotron Radiation Circular Dichroism. Ang, D. L.;
Jones, N. C.; Stootman, F.; Ghadirian, B.; Aldrich-Wright, J.. Nucleic Acids
Forum, London, UK, July 2016.
Relevance: This poster presented my work as presented in Chapter 1 on DNA
binding affinity calculations using SRCD.8
Poster 4: Molecular dynamics studies of the E. coli division protein FtsZ. Ang, D.
L.; Broughton, C.; Khalid, S.; Rodger, A.. Circular Dichroism summer school,
Warwick University, UK, July 2016.
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Relevance: My molecular dynamics simulation work performed at Warwick Uni-
versity on proteins is summarised in this poster. It formed the basis of
my further expansion into complex simulation and visualisation. This is
unpublished work.
Poster 5: Probing QDNA platinum(II) complex interactions with ESI-MS. Ang, D.
L.; Craze, A.; Yuliani, Y.; Kelso, C.; Beck, J.; Harman, D. G.; Ralph, S. F.;
Aldrich-Wright, J. R.. Pacifichem, Hawaii, Dec 2015.
Relevance: This poster was a summary of the work contained in the paper
presented in Chapter 3.
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5.5 Scholarships and grants awarded
During my candidature I have been awarded several scholarships and grants
which enabled me to explore and expand on my research. The details of these are
listed here in chronological order.
Grant 1: Marie Curie Fellowship, 2016. The Centre for Analytical Science In-
novative Doctoral Programme (CAS-IDP) was funded by the EU under FP7
Marie Curie Actions to train an international group of early stage researchers.
This project received funding from the European Union’s Seventh Framework
Programme for research, technological development and demonstration
under grant agreement number 316630.
Outcome: My Fellowship involved 12 months at Warwick University, Coventry,
UK, under the supervision of Professor Alison Rodger. During this time I
furthered my understanding of CD and LD spectroscopy, began development
of SOMSpec, and gained significant molecular dynamics expertise simulating
proteins and DNA. Several other projects were started here and will be
published in the near future.
Grant 2: Endeavour Research Fellowship, 2016. This highly competitive scholar-
ship is offered by the Australian Government to participate in short-term (4–6
months) research with an international University.
Outcome: I declined this offer as I was also offered the Marie Curie Fellowship and
the placements clashed.
Grant 3: Diamond Light Source, UK, September 2016. Reference: SM14808-1.
Title: SRCD Characterisation of unusual DNA structures. Principal investigator:
Janice Aldrich-Wright.
Outcome: This funded a 24 h window of experiments on the synchrotron circular
dichroism beamline at Diamond Light Source, UK. Several QDNA CD spectra
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were obtained and melt temperatures measured. These will contribute to the
library of QDNA CD spectra for the SOMSpec training sets. This project was
designed and performed solely by myself.
Grant 4: Australian Synchrotron Round ISAP 2015/1, ID: ISP9258. Title: Char-
acterisation of quadruplex DNA motifs by Synchrotron Radiation Circular
Dichroism (SRCD). Type: International. Principal scientist: Janice Aldrich-
Wright.
Outcome: This funded 6.5 days of access on the synchrotron circular dichroism
beamline at ISA, Aarhus University, Denmark. This work laid the foundation
for investigating QDNA binding using synchrotron radiation circular dichro-
ism (see Chapter 2). These experiments were all designed and optimised
by myself and most were performed by myself with assistance from my
supervisor. All post-processing of data was performed by myself.
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Chapter 6
Conclusions and future work
A key goal of this work was to gain a deeper understanding of the binding
of small molecules with biomacromolecular structures with a specific emphasis
on QDNA, leading to the design of improved biologically active platinum(II)
complexes. Towards this goal I was motivated to develop new tools to automate
and assess the spectral data obtained from the various experimental methods. In
Chapter 1 a new method for determining binding constants was presented and
implemented.8 This method allows near real time processing of spectra as it is
acquired. As a consequence, the prompt calculation of binding constants and
critical feedback on the quality of acquired spectra, reducing potential acquisition
errors, is made possible. The results also shed light on possible wavelength specific
methodology considerations when considering the design of binding experiments.
In Chapter 2, QDNA binding of a series of dinuclear platinum(II)-terpyridine
complexes was assessed. These were shown to exhibit strong stabilising effects and
specificity towards QDNA, increasing melting temperatures by up to 17 ◦C, while
not significantly affecting the conformation.1 The SOS-linked complex favoured the
parallel topologies of QDNA over dsDNA. Competitive FRET experiments revealed
that the dipyridal-linked complex exhibited especially high selectivity towards
QDNA in the presence of up to a 600-fold concentration of dsDNA, with no change
in the increased melt temperatures of the dsDNA. These are significant findings and
suggest this family of complexes should be pursued for further development and
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understand why dsDNA precipitation occurred.
The effect of methylation on the phenanthroline moiety of a series of
platinum(II)-phenanthroline complexes was then investigated by ESI-MS, molec-
ular docking simulations and associated techniques, in regard to binding with
QDNA and dsDNA in Chapter 3. Additionally, an improved method for the
preparation of oligonucleotides for ESI-MS experimentation was presented. The
results highlighted some important structural characteristics to consider when
designing bioactive platinum(II)-phenanthroline complexes specifically targeting
QDNA.
Chapter 4 presents SOMSpec, a software application I began developing in
my time at the University of Warwick for the elucidation of secondary structure
information from spectra. What started as a request from my supervisor to
“Take a look and see what you can do” morphed into a fully fledged stand alone
machine learning program, currently at around ten thousand lines of code. This
substantially increased my understanding of the informational content obtained
through spectrophotometric methods, and served as an introduction to machine
learning algorithms. SOMSpec is in active development with the ultimate aim
to create a suite of integrated tools allowing the experimentalist to process,
manipulate, predict and present spectra from a variety of sources including CD,
UV, IR, and RAMAN. SOMSpec is in active development and the implementation
of automated binding calculations as presented in Chapter 1 is a current priority,
which should also increase the uptake of this method. Finally, the implementation
of more advanced machine learning algorithms within SOMSpec is in the pipeline
and should yield improved prediction accuracy and training speed.
Future directions of this research include the further development of the
dinuclear platinum(II)-terpyridine complexes, investigated in chapter 2, to improve
the stabilisation effects of QDNA and to further increase specificity. Alongside this, a
family of symmetric platinum(II)-phenanthroline complexes have been synthesised,
based on the findings of Chapter 3, with initial QDNA melt data showing promising
stabilisation properties. This data will be the subject of a paper in the near future.
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Also critical is the parameterisation of these platinum(II) complexes to enable full
molecular dynamics simulations in the presence of DNA as an improved way of
exploring these interactions over rudimentary docking methodologies.
As part of the experiments performed at the Diamond Light Source, UK, and the
ISA, Denmark, synchrotron CD beamlines I have compiled a library of synchrotron
radiation CD (SRCD) melt spectra of various DNA topologies. The aim is for this
data to become a useful reference set complementing the Protein Circular Dichroism
Data Bank33 and as a training set for SOMSpec to enable the prediction of DNA
motifs.
Finally, but crucially related this work, is the pressing need to adopt a better CD
instrument calibration standard than camphorsulfonic acid (CSA), especially for
benchtop instruments. CSA is considered the primary standard for CD calibration,
but is highly hygroscopic.34 The related, less hygroscopic secondary standard
ammonium camphor sulfonate (ACS) is sometimes used as it is easier to measure,
but less stable in storage. For both, there is only one hand readily available with
a (very broad) positive peak at 290 and negative peak at 192.5 nm. A machine
is considered within ’spec’ if the ratio of ellipticities of the two peaks is ~1.90–
2.20.35 Difficulties arise for most benchtop in this situation as it is difficult to
adequately resolve the 192.5 nm peak due to atmospheric absorption and poor
lamp intensity. This also doesn’t provide any information on machine performance
at longer wavelengths. As part of an ongoing collaboration to create a new CD
standard for calibrating CD machines based on the chiral Co[EDDS] complex,36
I have been developing a piece of software and associated methodology for the
automated interpretation of the CD spectrum calibration results. The aim is to
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the published articles from Chapters 1–3. For Chapter 4, the SOMSpec user guide
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1. Supplementary information for the Chapter 1 paper "Improved DNA Equilibrium
Binding Affinity Determinations of Platinum(II) Complexes using Synchrotron Ra-
diation Circular Dichroism". Includes description of input data formats, derivation
of the binding equation, and SRCD data from binding experiments.
2. Supporting information for the Chapter 2 paper "Quadruplex DNA-Stabilising
Dinuclear Platinum(II) Terpyridine Complexes with Flexible Linkers". Includes the
SRCD melt spectra and curves, FID competition spectra, FRET melting results, DFT
calculations, and docking simulation details.
3. Supplementary information for the Chapter 3 paper "A study of Pt(II)-
phenanthroline complex interactions with double-stranded and G-quadruplex DNA
by ESI-MS, circular dichroism, and computational docking". Includes ESI-MS
spectra from the quadruplex and double stranded binding experiments, HPLC
traces, calculated partial atomic charges, electrostatic potential maps, and Gaussian
input files.
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Input Data File CSV format
The Mathematica notebook accepts a standard CSV file; the path of which must be 
specified within the notebook. The format is as follows. Cell A1 contains the DNA 
concentration [M]. The first column contains the wavelengths. Subsequent columns 
contain the blank/buffer, DNA, followed by the DNA + MC data at the various 
concentrations.
An example is shown below.
[DNA conc]
Blank/buffer DNA, no MC DNA + MC conc 1







0 0 0.00000166 0.00000332
400 0.366 0.475 0.397 0.415
399 0.355 0.442 0.426 0.467
398 0.346 0.455 0.412 0.437
397 0.345 0.457 0.443 0.441
396 0.384 0.511 0.418 0.416
4
Equation Derivation
In what follows we use the following labels for description: LF (free metal 
complex concentration), SF (free binding site concentration), LB (bound metal 
complex concentration), SB (bound/occupied binding site concentration), LT (total 
metal complex concentration) and ST (total binding site concentration).
In the original development of the theory the binding equilibrium rate equation 









The value of K is assumed to be a constant at a given wavelength and 
independent of LB. Substituting for LF = LT − LB and SF = ST − SB into Eq. (1) and 
making a reasonable assumption that SB = LB, results in a quadratic equation for LB 
which has a solution of 
5
( 2 )
𝐿𝐵 = 0.5𝑅(1𝐾 + 𝐿𝑇 + 𝑆𝑇 ‒ (1𝐾 + 𝐿𝑇 + 𝑆𝑇)2 ‒ 4𝑆𝑇𝐿𝑇)
where  is a scaling constant, and LB is directly proportional to the measured R
normalized molar absorption coefficient, . The value of K can be found by fitting M
the titration data directly in Eq. (2), which is the preferred approach.1 The number of 
DNA binding sites, n, is related to the total DNA concentration and calculated where 
n = [DNA]/ST.
In the literature, however, Scatchard,2 Schmechel and Crothers3 and 
others4-6 have attempted to linearize Eq. (1) by approximation. Substituting the above 




(𝐿𝑇 ‒ 𝐿𝐵)(𝑆𝑇 ‒ 𝐿𝐵)










At this point a further assumption is made that at low total ligand 
concentration LB → LT on the RHS of Eq. (4). This implies that by this method K is an 
extrapolation as LB → 0; this is at best artificial because K is determined when there is 
effectively no binding. Such an assumption is not made by Eq. (2). In the literature 
6
Eq. (4) leads to a more traditional form in order to determine K by using  M























Plotting the experimentally derived  versus  yields a value of M B  T BS L
slope and intercept from which K, again extrapolated to LB → 0, is found. If the plot is 
not a straight line (as mathematically it is not), it is argued that a value of K can be 
found from the initial slope of the graph. Both approaches determine artificially the 
binding constant at very low bound ligand concentrations.
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Binding Data obtained from SRCD experiments
Table S1 Complex 1, [Pt(phen)(en)]2+ binding data, experiment B.
Wavelength Binding Constant Estimated Binding sites
nm K × 105 per complex, n
297 1.1 ± 0.54 2.4 ± 0.1
320 5.8 ± 0.40 4.3 ± 0.2 
Figure S1 Expt B – SRCD and ISRCD spectra at different concentrations of 
metal complex 1, into calf thymus DNA in PS buffer. 
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Table S2 Complex 2, [Pt(4-Mephen)(en)]2+ binding data, experiment A.
Wavelength Binding Constant Estimated Binding sites
nm K × 104 per complex, n
181 2.14 ± 0.84 2.6 ± 0.1
185 0.76 ± 0.09 3.6 ± 0.1
186 1.08 ± 0.15 3.3 ± 0.1
190 1.75 ± 0.25 2.8 ± 0.1
192 1.79 ± 0.14 2.4 ± 0.1
194 3.37 ± 0.95 2.1 ± 0.1
195 1.46 ± 0.21 2.1 ± 0.5
Figure S2 Expt A – SRCD and ISRCD spectra at different concentrations of 
metal complex 2, into ct-DNA in PS buffer.
9
Table S3 Complex 2, [Pt(4-Mephen)(en)]2+ binding data, experiment B.
Wavelength Binding Constant Estimated Binding sites
nm K × 104 per complex, n
177 11.6 ± 3.0 2.4 ± 0.2
184 0.95 ± 0.52 1.6 ± 0.0
186 1.8 ± 0.74 1.7 ± 0.1
192 3.4 ± 0.52 1.6 ± 0.0
194 6.3 ± 3.5 1.5 ± 0.0
Figure S3 Expt B - SRCD and ISRCD spectra at different concentrations of metal 
complex 2, into ct-DNA in PS buffer. 
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Table S4 Complex 3, [Pt(5-Mephen)(en)]2+ binding data, experiment A.
Wavelength Binding Constant Estimated Binding sites
nm K × 105 per complex, n
192 2.33 ± 0.18 2.2 ± 0.0
193 3.34 ± 0.22 2.2 ± 0.0
221 1.32 ± 0.78 6.5 ± 1.0
 
Figure S4 Expt A - SRCD and ISRCD spectra at different concentrations of metal 
complex 3, into ct-DNA in PS buffer. 
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Table S5 Complex 3, [Pt(5-Mephen)(en)]2+ binding data, experiment B.
Wavelength Binding Constant Estimated Binding sites
nm K × 104 per complex, n
181 4.5 ± 1.9 2.5 ± 0.1
185 5.8 ± 1.2 2.5 ± 0.1
191 8.5 ± 0.73 2.4 ± 0.1
208 5.2 ± 1.2 4.0 ± 0.2
210 5.6 ± 0.87 3.6 ± 0.2
213 2.7 ± 0.86 3.9 ± 0.1
214 2.2 ± 0.42 4.0 ± 0.2
215 2.4 ± 0.75 3.8 ± 0.1
218 1.2 ± 0.47 6.0 ± 0.2
279 0.46 ± 0.10 1.9 ± 0.0
330 7.0 ± 0.78 3.9 ± 0.3
Figure S5 Expt B - SRCD and ISRCD spectra at different concentrations of metal 
complex 3, into ct-DNA in PS buffer. 
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Table S6 Complex 4, [Pt(4,7-Me2phen)(en)]2+ binding data, experiment A.
Wavelength Binding Constant Estimated Binding sites
nm K × 104 per complex, n
194 4.7 ± 0.61 2.6 ± 0.2
195 3.4 ± 0.70 2.4 ± 0.1
199 0.35 ± 0.09 1.9 ± 0.0
307 33 ± 1.5 2.4 ± 0.1
312 24 ± 1.4 2.2 ± 0.1
336 1.4 ± 0.2 2.1 ± 0.1
 
Figure S6 Expt A - SRCD and ISRCD spectra at different concentrations of metal 
complex 4, into ct-DNA in PS buffer. 
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Table S7 Complex 4, [Pt(4,7-Me2phen)(en)]2+ binding data, experiment B.
Wavelength Binding Constant Estimated Binding sites
nm K × 105 per complex, n
184 3.5 ± 0.28 2.0 ± 0.1
209 1.9 ± 0.12 3.2 ± 0.1
311 8.6 ± 0.76 3.6 ± 0.2
  
Figure S7 Expt B - SRCD and ISRCD spectra at different concentrations of metal 
complex 4, into calf thymus DNA in PS buffer. 
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Table S8 Complex 5, [Pt(5,6-Me2phen)(en)]2+ binding data, experiment A.
Wavelength Binding Constant Estimated Binding sites
nm K × 104 per complex, n
207 13.4 ± 0.96 3.3 ± 0.1
210 6.9 ± 0.41 3.2 ± 0.0
212 5.6 ± 0.33 3.1 ± 0.0
214 7.3 ± 0.27 3.3 ± 0.0
215 9.1 ± 0.52 3.3 ± 0.0
216 9.8 ± 0.34 3.2 ± 0.0
220 3.3 ± 0.21 4.8 ± 0.1
241 0.53 ± 0.10 1.6 ± 0.0
242 2.0 ± 0.35 2.0 ± 0.1
298 2.2 ± 0.22 2.5 ± 0.1
300 0.81 ± 0.20 2.8 ± 0.1
Figure S8 Expt A - SRCD and ISRCD spectra at different concentrations of metal 
complex 5, into ct-DNA in PS buffer. 
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Table S9 Complex 5, [Pt(5,6-Me2phen)(en)]2+ binding data, experiment B.
Wavelength Binding Constant Estimated Binding sites
nm K × 104 per complex, n
176 6.2 ± 0.98 1.4 ± 0.1
181 7.4 ± 1.5 2.3 ± 0.1
183 2.9 ± 0.37 2.4 ± 0.1
185 2.5 ± 0.13 2.4 ± 0.1
186 3.5 ± 0.35 2.3 ± 0.1
191 4.0 ± 1.4 2.2 ± 0.1
193 5.1 ± 0.39 2.0 ± 0.1
235 10 ± 0.73 2.7 ± 0.1
259 5.3 ± 0.54 2.8 ± 0.1
260 1.7 ± 0.20 3.2 ± 0.1
261 1.8 ± 0.16 3.0 ± 0.1
262 3.8 ± 0.73 2.7 ± 0.1
269 8.5 ± 0.43 2.6 ± 0.0
304 2.4 ± 0.23 2.1 ± 0.0
329 3.6 ± 1.9 3.0 ± 0.2
 
Figure S9 Expt B - SRCD and ISRCD spectra at different concentrations of metal 
complex 5, into ct-DNA in PS buffer. 
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Table S10 Complex 6, [Pt(3478-Me4phen)(en)]2+ binding data, experiment A.
Wavelength Binding Constant Estimated Binding sites
nm K × 105 per complex, n
208 0.77 ± 0.13 4.9 ± 0.4
254 0.71 ± 0.07 6.0 ± 0.4
261 0.10 ± 0.01 5.2 ± 0.1
323 2.5 ± 0.27 4.5 ± 0.2
330 1.1 ± 0.10 9.8 ± 0.5
Figure S10 Expt A - SRCD and ISRCD spectra at different concentrations of metal 
complex 6, into ct-DNA in PS buffer. 
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Table S11 Complex 6, [Pt(3478-Mephen)(en)]2+ binding data, experiment B
Wavelength Binding Constant Estimated Binding sites
nm K × 104 per complex, n
300 1.6 ± 0.15 3.5 ± 0.1
301 2.4 ± 0.20 4.7 ± 0.1
323 0.5 ± 0.19 5.4 ± 0.2
 
Figure S11 Expt B - SRCD and ISRCD spectra at different concentrations of metal 
complex 6, into calf thymus DNA in PS buffer. 
18
References
1. F. H. Stootman, D. M. Fisher, A. Rodger and J. R. Aldrich-Wright, The 
Analyst, 2006, 131, 1145-1151.
2. G. Scatchard, Ann. N. Y. Acad. Sci., 1949, 51, 660-672.
3. D. E. Schmechel and D. M. Crothers, Biopolymers, 1971, 10, 465-480.
4. S. Sarkar and B. Das, Complex Metals, 2014, DOI: 
10.1080/2164232X.2014.887448, 80-87.
5. H. Wu, F. Kou, F. Jia, B. Liu, J. Yuan and Y. Bai, Bioinorganic Chemistry 
and Applications, 2011, 2011.
6. A. M. Pyle, J. P. Rehmann, R. Meshoyrer, C. V. Kumar, N. J. Turro and J. K. 
Barton, Journal of the American Chemical Society, 1989, 111, 3051-3058.
Supporting Information
Quadruplex DNA-Stabilising Dinuclear Platinum(II) Terpyridine
Complexes with Flexible Linkers






Table of contents 
Table of contents .................................................................................................. 1 
SRCD Acquisition ................................................................................................ 1 
SRCD Melt Spectra .............................................................................................. 2 
FID Competition ................................................................................................... 3 
DFT Calculations.................................................................................................. 4 
Docking Simulations ............................................................................................ 5 
SRCD Melt Curve Fits ......................................................................................... 5 





Specifications of ASTRID include a maximum energy of 580 MeV, a wavelength range of 
125–600 nm, maximum flux (180 and 240 nm) of 10
12
 photons/s, a TGM monochromator 
with a CaF2 window and a variable sample beam size between 2 × 1 mm to 6 × 2 mm, a 
sample detector distance of 25 mm and a bandwidth of 0.6 mm. Daily calibration was 
achieved by determination of the ratio of D-10-camphorsulfonic acid (CSA) peaks at 192 and 







SRCD Melt Spectra 
 
Figure S1. SRCD melt spectra of 1 (A), 2 (B), 3 (C) and 4 (D) with Q1 at a 1:1 MC:QDNA 
ratio (left). Thermally induced change in SRCD signal as a function of temperature with 1, 2, 







Figure S2. Graphical representation of TO displacement from c-myc QDNA (), HTelo 
QDNA () and ds26 duplex DNA () upon increasing concentration of complex 4 (above), 




   
Figure S3. FRET melting results of experiments carried out with F-myc (left), F21T-HTelo 
(center) and DS1-T (right) with increasing concentration of 2 from 0-4 µM. 
 
   
Figure S4. FRET melting results of experiments carried out with F-myc (left), F21T-HTelo 
(center) and DS1-T (right) with increasing concentration of 3 from 0-4 µM. 
 
DFT Calculations 
The optimised structures of 1-3 show a Pt-S distance of 2.376 Å with the Pt metal centrally 
placed within the ligand (Pt-Ncis distance 2.005 Å; Pt-Ntrans distance 2.062 Å; Ncis-Pt-Ntrans 
dihedral 80°). Structure 4 shows a Pt-NPyr distance of 2.107 Å with the Pt metal centrally 
placed within the ligand (Pt-Ncis distance 1.972 Å; Pt-Ntrans distance 2.073 Å; Ncis-Pt-Ntrans 
dihedral 87°). These values are in good agreement with experimental values previously 
reported for Pt-terpyridine complexes.
2
 The pyridine rings of 1-4 are all coplanar; the Pt-S-C 
dihedral for 1-3 was ~103°, the pyridine linker of 4 perpendicular to the plane. Linker lengths 
from Pt–Pt were 10.2 Å (1), 14.6 Å (2), 19.1 Å (3) and 18.7 Å (4). 











































































Preparation of the DNA substrates included removal of solvent molecules and assignment of 
polar hydrogens. The grid boxes were defined to encompass the entire structureof the relevant 
PDB entry. Each docking simulation was carried out with five repeats and an exhaustiveness 
value of 64. 
 
SRCD Melt Curve Fits 
 






Figure S6. Melt curves of Q1 incubated with 1. 
 
 





Figure S8. Melt curves of Q1 incubated with 3. 
 
 





Figure S10. Melt curves of Q2 only. 
 
 





Figure S12. Melt curves of Q3 only. 
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ESI -MS data processing methodology
• Relative abundance refers to the normalised amount of DNA in complex with ligand 
as a percentage of all DNA (calculated from the sums of relative intensities of ions 
from the DNA:ligand divided by the sum of intensities of all ions in the ESI mass 
spectrum). The percentage bound DNA is calculated using the equation:
 
• Initial processing steps within MassLynx:
a. Identify the major abundance charge states, typically 4−, 5−, 6−;
b. Zoom into the area of interest (Display → Range → From… 1600–3000 m/z 
for G4DNA, 1100–2800 m/z for dsDNA);
c. Process → Background Subtract (Polynomial order: 2, Below curve: 40, 
Tolerance: 0.010);
d. Process → Spectrum Smooth (Smooth window: 20, Number of smooths: 1, 
Savitzky-Golay);
e. Search the Display → List Spectrum, record, enter into spreadsheet to 
calculate %bound.
• Raw ESIMS data and calculations are contained in SUPP_ESIMS_results.pdf.
%bound=
[ DNA : ligand ]
[DNA+DNA : ligand ]
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ESI-MS Spectra
Conditions: Mass spectra were obtained in ESI negative mode using a Waters XEVO QToF 
ESI mass spectrometer with a Z-spray ionisation source. Spectra were obtained with an MCP 
potential of 2.4 kV, a cone voltage of 25 V, capillary tip potential of 2.3 kV and the 
extraction cone at 4.0 V. The desolvation gas (nitrogen) flow was 150 L hr−1 at 150 °C, cone 
gas flow 20 L hr−1, with a source temperature of 70 °C. Sample solutions were infused using a
KD Scientific Model 100 syringe pump, at a flow rate of 5 μL min-1. A lockspray solution of 
200 pg μL−1 leucine enkephalin in 50% aqueous acetonitrile plus 0.1% formic acid was 
infused at 5 μL min−1 simultaneously, in order to enable mass accuracy correction.  All 
sample spectra were obtained in ESI negative ion mode over a 50–4000 m/z range. 
MassLynx v4.1 was used for the processing of spectra. A 5 min window of the total ion 
chromatogram was combined, and the region from 1200–3000 m/z chosen so as to 
encompass all visible charge states. All samples were prepared at 1:1, 5:1 and 10:1 PC:DNA 
ratios, vortexed and adjusted to a final volume of 25 μL. The solutions were vortexed and 
equilibrated at room temperature for 5 min before injection. DNA concentration in each 
sample was 10 μM. The solution was vortexed and equilibrated at room temperature for 
5 min before injection. Sequences: G4DNA = 5`-TTG GGG GT-3`, dsDNA = 5`-CGC GAA 
TTC GCG-3`.
PC:DNA ratios used. Lower = 1:1, Middle = 5:1, Upper = 10:1. The 10:1 ratio ESI-MS 
spectra for dsDNA are omitted due to excessive noise.
ESI-MS Spectra of G4DNA+PC
Figure 1: Negative ion ESI mass spectra of G4DNA with 1 [Pt(en)
(phen)]Cl2
117
Figure 2: Negative ion ESI mass spectra of G4DNA with 2 [Pt(en)(4-
mephen)]Cl2
Figure 3: Negative ion ESI mass spectra of G4DNA with 3 [Pt(en)(5-
mephen)]Cl2
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Figure 4: Negative ion ESI mass spectra of G4DNA with 4 [Pt(en)
(4,7-me2phen)]Cl2
Figure 5: Negative ion ESI mass spectra of G4DNA with 5 [Pt(en)
(5,6-me2phen)]Cl2
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ESI-MS Spectra of dsDNA+PC
Figure 6: Negative ion ESI mass spectra of G4DNA with 6 [Pt(en)
(3,4,7,8-me4phen)]Cl2
Figure 7: Negative ion ESI mass spectra of dsDNA with 1 [Pt(en)
(phen)]Cl2
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Figure 8: Negative ion ESI mass spectra of dsDNA with 2 [Pt(en)(4-
mephen)]Cl2
Figure 9: Negative ion ESI mass spectra of dsDNA with 3 [Pt(en)(5-
mephen)]Cl2
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Figure 10: Negative ion ESI mass spectra of dsDNA with 4 [Pt(en)
(4,7-me2phen)]Cl2
Figure 11: Negative ion ESI mass spectra of dsDNA with 5 [Pt(en)
(5,6-me2phen)]Cl2
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Table S1: Retention times and corrected retention times (k`) for each complex.





1 [Pt(en)(phen)]Cl2 1.487 6.223 4.736
2 [Pt(en)(4-Mephen)]Cl2 1.485 7.273 5.788
3 [Pt(en)(5-Mephen)]Cl2 1.485 7.423 5.938
4 [Pt(en)(4,7-Me2phen)]Cl2 1.489 8.317 6.828
5 [Pt(en)(5,6-Me2phen)]Cl2 1.490 8.477 6.987
6 [Pt(en)(3,4,7,8-Me4phen)]Cl2 1.586 10.020 8.434
HPLC traces
Conditions: Analytical reverse-phase HPLC (RP-HPLC) of the PCs was performed on an 
Agilent Technologies 1260 Infinity, equipped with a Phenomenex C18 reverse phase column 
(4.6 × 150 mm, 5 μm). The mobile phase consisted of solvent A (0.06% TFA in water) and 
solvent B (0.06% TFA in ACN:H2O) (90:10). Samples were injected and eluted with a 
gradient of 0–40 (% B) over 15 min at a flow rate of 1 mL min-1. Detection was by 
photodiode array at 254 nm and 214 nm. Reported retention times were corrected by 
subtracting the elution time of a non-retained compound.
Figure S13 RP-HPLC trace of 1 [Pt(en)(phen)]Cl2, 5 μm C18 column, 0–40 (% H2O–ACN:H2O) @ 1 mL min-1, UV 
detection at 254 nm (upper) and 214 nm (lower).
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Figure S14 RP-HPLC trace of 2 [Pt(en)(4-Mephen)]Cl2, 5 μm C18 column, 0–40 (% H2O–ACN:H2O) @ 1 mL min-1, UV 
detection at 254 nm (upper) and 214 nm (lower).
Figure S15 RP-HPLC trace of 3 [Pt(en)(5-Mephen)]Cl2, 5 μm C18 column, 0–40 (% H2O–ACN:H2O) @ 1 mL min-1, UV 
detection at 254 nm (upper) and 214 nm (lower).
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Figure S16 RP-HPLC trace of 4 [Pt(en)(4,7-Me2phen)]Cl2, 5 μm C18 column, 0–40 (% H2O–ACN:H2O) @ 1 mL min-1, UV 
detection at 254 nm (upper) and 214 nm (lower).
Figure S17 RP-HPLC trace of 5 [Pt(en)(5,6-Me2phen)]Cl2, 5 μm C18 column, 0–40 (% H2O–ACN:H2O) @ 1 mL min-1, UV 
detection at 254 nm (upper) and 214 nm (lower).
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Figure S18 RP-HPLC trace of 6 [Pt(en)(3,4,7,8-Me4phen)]Cl2, 5 μm C18 column, 0–40 (% H2O–ACN:H2O) @ 1 mL min-1, 
UV detection at 254 nm (upper) and 214 nm (lower).
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Elution time versus % DNA bound
Table S2: Data for % bound DNA at 1:1 PC:DNA ratio.
PC K` /min % Bound G4 % Bound D2
1 4.74 32 48
2 5.79 41 66
3 5.94 45 57
4 6.83 54 67
5 6.99 56 70
6 8.43 80 51
Figure S19: Plots of corrected elution time vs % bound DNA for G4 and D2 at 1:1 PC:DNA 
ratio.
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Calculated partial atomic charges
Table S3: Calculated Mullikan charges for each complex. Atom descriptors: ar = aromatic, 
en = ethylenediamine.
Complex
Atom ID Atom 1 2 3 4 5 6
1 Pt 0.7227 0.7220 0.7217 0.7188 0.7220 0.7137
2 N (ar) -0.6662 -0.6773 -0.6698 -0.6755 -0.6748 -0.6777
3 C (ar) 0.2611 0.2571 0.2597 0.2583 0.2566 0.2059
4 C (ar) 0.0846 0.0390 0.0808 0.0263 0.0757 0.0693
5 C (ar) 0.1214 0.1167 0.1057 0.1311 0.0977 0.0856
6 C (ar) 0.1263 0.1060 0.0976 0.1062 0.1156 0.1129
7 C (ar) 0.2997 0.3023 0.3040 0.2947 0.2972 0.2939
8 C (ar) 0.2997 0.2924 0.2942 0.2947 0.2972 0.2909
9 C (ar) 0.1263 0.1300 0.1445 0.1062 0.1156 0.1110
10 C (ar) 0.0612 0.0508 -0.0162 0.0371 0.0426 0.0239
11 C (ar) 0.0612 0.0447 0.1107 0.0371 0.0425 0.0280
12 C (ar) 0.1214 0.1186 0.1151 0.1311 0.0977 0.0948
13 C (ar) 0.0846 0.0821 0.0805 0.0263 0.0757 0.0654
14 C (ar) 0.2611 0.2589 0.2556 0.2583 0.2566 0.2051
15 N (ar) -0.6663 -0.6668 -0.6695 -0.6755 -0.6748 -0.6756
16 N (en) 0.0490 0.0475 0.0485 0.0476 0.0479 0.0471
17 C (en) 0.3017 0.2997 0.3006 0.2978 0.2989 0.2951
18 C (en) 0.3017 0.2995 0.3005 0.2978 0.2989 0.2951
19 N (en) 0.0490 0.0480 0.0479 0.0476 0.0479 0.0470
20 C (methyl) - - - - - 0.0806
21 C (methyl) - 0.1287 - 0.1170 - 0.1068
22 C (methyl) - 0.0879 - 0.0815 -
23 C (methyl) - - - - 0.0815 -
24 C (methyl) - - - 0.1170 - 0.1019




Figure S20: Boxplot of calculated Mullikan charges for each complex.
Electrostatic potential maps







#P B3LYP/Gen Pseudo=Read Opt
 C14H16N4Pt | Equilibrium Geometry | B3LYP/Gen
2 1
Pt    -2.208000   -0.125000    0.029000
N     -4.249000   -0.135000    0.036000
C     -3.056000    2.820000   -0.154000
C     -2.735000    4.185000   -0.220000
C     -1.390000    4.589000   -0.204000
C     -0.376000    3.623000   -0.126000
C     -0.746000    2.274000   -0.062000
N     -2.055000    1.901000   -0.072000
C      0.235000    1.267000    0.012000
Figure S22: Frontier molecular orbitals of the Pt(II)-phenanthroline complexes studied.
131
C      1.595000    1.597000    0.028000
C      1.973000    2.953000   -0.034000
C      0.991000    3.962000   -0.112000
C      0.714000   -1.056000    0.154000
C      2.090000   -0.774000    0.173000
C      2.532000    0.557000    0.108000
H     -4.090000    2.514000   -0.173000
H     -3.523000    4.924000   -0.284000
H     -1.145000    5.642000   -0.256000
H      0.379000   -2.079000    0.210000
H      2.807000   -1.582000    0.240000
H      3.594000    0.772000    0.124000
N     -0.176000   -0.030000    0.069000
N     -2.278000   -2.164000    0.079000
C     -4.598000   -1.498000    0.435000
C     -3.661000   -2.483000   -0.272000
H     -4.452000   -1.611000    1.532000
H     -4.589000    0.054000   -0.935000
H     -3.801000   -2.364000   -1.369000
H     -2.071000   -2.483000    1.054000
H     -4.656000    0.542000    0.719000
H     -1.633000   -2.610000   -0.611000
H     -5.663000   -1.710000    0.196000
H     -3.897000   -3.534000    0.003000
H      3.020000    3.229000   -0.023000
H      1.297000    5.000000   -0.160000











#P B3LYP/Gen Pseudo=Read Opt
 C15H18N4Pt | Equilibrium Geometry | B3LYP/Gen
2 1
Pt    -2.284000   -0.049000    0.244000
N     -4.325000   -0.003000    0.275000
C     -3.061000    2.883000   -0.190000
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C     -2.711000    4.228000   -0.380000
C     -1.358000    4.598000   -0.414000
C     -0.365000    3.619000   -0.260000
C     -0.760000    2.292000   -0.073000
N     -2.079000    1.953000   -0.036000
C      0.201000    1.269000    0.081000
C      1.579000    1.562000    0.055000
C      1.968000    2.915000   -0.134000
C      1.003000    3.928000   -0.290000
C      0.600000   -1.047000    0.425000
C      1.979000   -0.821000    0.409000
C      2.492000    0.480000    0.223000
H     -4.101000    2.602000   -0.172000
H     -3.482000    4.977000   -0.503000
H     -1.089000    5.637000   -0.562000
H      0.229000   -2.047000    0.576000
H      2.654000   -1.658000    0.543000
N     -0.250000   -0.004000    0.256000
N     -2.408000   -2.074000    0.473000
C     -4.704000   -1.315000    0.797000
C     -3.805000   -2.384000    0.168000
H     -4.545000   -1.336000    1.898000
H     -4.673000    0.110000   -0.704000
H     -3.958000   -2.357000   -0.934000
H     -2.196000   -2.313000    1.469000
H     -4.705000    0.742000    0.902000
H     -1.787000   -2.596000   -0.185000
H     -5.778000   -1.517000    0.591000
H     -4.064000   -3.400000    0.537000
C      3.994000    0.633000    0.219000
H      3.002000    3.212000   -0.165000
H      1.326000    4.952000   -0.434000
H      4.366000    1.659000    0.072000
H      4.422000    0.011000   -0.596000
H      4.400000    0.273000    1.188000












#P B3LYP/Gen Pseudo=Read Opt
 C15H18N4Pt | Equilibrium Geometry | B3LYP/Gen
2 1
Pt    -2.199000   -0.124000    0.029000
N     -4.240000   -0.127000    0.038000
C     -3.039000    2.815000   -0.154000
C     -2.719000    4.179000   -0.221000
C     -1.374000    4.581000   -0.204000
C     -0.360000    3.614000   -0.125000
C     -0.726000    2.269000   -0.061000
N     -2.037000    1.898000   -0.071000
C      0.256000    1.260000    0.013000
C      1.627000    1.585000    0.031000
C      2.005000    2.964000   -0.033000
C      1.000000    3.958000   -0.111000
C      0.706000   -1.071000    0.157000
C      2.079000   -0.811000    0.178000
C      2.544000    0.511000    0.113000
H     -4.072000    2.510000   -0.174000
H     -3.506000    4.919000   -0.286000
H     -1.129000    5.634000   -0.256000
H      0.358000   -2.090000    0.214000
H      2.783000   -1.630000    0.246000
H      3.609000    0.663000    0.133000
N     -0.167000   -0.035000    0.070000
N     -2.278000   -2.164000    0.075000
C     -4.595000   -1.488000    0.436000
C     -3.664000   -2.476000   -0.274000
H     -4.447000   -1.604000    1.533000
H     -4.581000    0.065000   -0.932000
H     -3.805000   -2.355000   -1.371000
H     -2.071000   -2.486000    1.049000
C      3.437000    3.443000   -0.023000
H      4.202000    2.653000    0.037000
H      3.591000    4.114000    0.848000
H      3.635000    4.019000   -0.952000
H     -4.644000    0.551000    0.723000
H     -1.638000   -2.612000   -0.618000
H     -5.661000   -1.695000    0.199000
H     -3.904000   -3.527000    0.000000
H      1.285000    5.003000   -0.161000












#P B3LYP/Gen Pseudo=Read Opt
 C16H20N4Pt | Equilibrium Geometry | B3LYP/Gen
2 1
Pt    -2.251000   -0.147000    0.029000
N     -4.292000   -0.189000    0.045000
C     -3.149000    2.769000   -0.151000
C     -2.867000    4.138000   -0.218000
C     -1.531000    4.588000   -0.205000
C     -0.485000    3.635000   -0.128000
C     -0.824000    2.277000   -0.063000
N     -2.127000    1.878000   -0.070000
C      0.177000    1.281000    0.009000
C      1.543000    1.627000    0.025000
C      1.880000    3.001000   -0.039000
C      0.881000    3.988000   -0.115000
C      0.667000   -1.040000    0.151000
C      2.036000   -0.760000    0.170000
C      2.497000    0.570000    0.105000
H     -4.175000    2.438000   -0.169000
H     -3.686000    4.845000   -0.281000
H      0.336000   -2.064000    0.208000
H      2.742000   -1.579000    0.236000
N     -0.223000   -0.020000    0.066000
N     -2.292000   -2.188000    0.072000
C     -4.620000   -1.558000    0.441000
C     -3.672000   -2.526000   -0.274000
H     -4.467000   -1.673000    1.537000
H     -4.640000   -0.001000   -0.924000
H     -3.819000   -2.405000   -1.370000
H     -2.076000   -2.508000    1.045000
H     -4.707000    0.478000    0.734000
H     -1.646000   -2.623000   -0.624000
H     -5.682000   -1.784000    0.206000
H     -3.891000   -3.582000   -0.001000
C      3.992000    0.780000    0.131000
H      4.326000    1.829000    0.081000
135
H      4.450000    0.250000   -0.731000
H      4.405000    0.351000    1.069000
C     -1.250000    6.066000   -0.278000
H     -2.186000    6.661000   -0.334000
H     -0.646000    6.290000   -1.183000
H     -0.693000    6.388000    0.628000
H      2.902000    3.339000   -0.032000
H      1.185000    5.025000   -0.162000











#P B3LYP/Gen Pseudo=Read Opt
 C16H20N4Pt | Equilibrium Geometry | B3LYP/Gen
2 1
Pt    -2.195000   -0.112000    0.028000
N     -4.237000   -0.124000    0.045000
C     -3.054000    2.803000   -0.157000
C     -2.761000    4.163000   -0.224000
C     -1.430000    4.593000   -0.209000
C     -0.370000    3.653000   -0.129000
C     -0.726000    2.295000   -0.063000
N     -2.037000    1.908000   -0.072000
C      0.255000    1.285000    0.012000
C      1.625000    1.603000    0.030000
C      2.018000    2.978000   -0.034000
C      1.017000    4.007000   -0.114000
C      0.698000   -1.053000    0.157000
C      2.067000   -0.799000    0.179000
C      2.536000    0.518000    0.114000
H     -4.081000    2.481000   -0.177000
H     -3.564000    4.886000   -0.291000
H     -1.267000    5.653000   -0.264000
H      0.346000   -2.069000    0.216000
H      2.768000   -1.622000    0.248000
H      3.601000    0.650000    0.136000
136
N     -0.169000   -0.012000    0.069000
N     -2.267000   -2.153000    0.070000
C     -4.585000   -1.489000    0.439000
C     -3.652000   -2.470000   -0.277000
H     -4.433000   -1.608000    1.535000
H     -4.583000    0.070000   -0.923000
H     -3.797000   -2.345000   -1.373000
H     -2.056000   -2.477000    1.041000
C      1.476000    5.458000   -0.182000
H      0.689000    6.222000   -0.242000
H      2.109000    5.608000   -1.081000
H      2.065000    5.706000    0.725000
C      3.484000    3.394000   -0.019000
H      4.226000    2.587000    0.042000
H      3.678000    4.047000    0.857000
H      3.723000    3.951000   -0.949000
H     -4.643000    0.546000    0.736000
H     -1.629000   -2.597000   -0.628000
H     -5.651000   -1.699000    0.204000
H     -3.887000   -3.522000   -0.006000











#P B3LYP/Gen Pseudo=Read Opt
 C18H24N4Pt | Equilibrium Geometry | B3LYP/Gen
2 1
Pt    -2.247000   -0.158000    0.031000
N     -4.289000   -0.177000    0.047000
C     -3.113000    2.762000   -0.153000
C     -2.832000    4.138000   -0.221000
C     -1.475000    4.576000   -0.203000
C     -0.441000    3.604000   -0.123000
C     -0.794000    2.250000   -0.058000
N     -2.098000    1.865000   -0.068000
C      0.198000    1.241000    0.017000
137
C      1.567000    1.568000    0.036000
C      1.917000    2.941000   -0.028000
C      0.930000    3.938000   -0.106000
C      0.654000   -1.087000    0.162000
C      2.035000   -0.839000    0.185000
C      2.515000    0.501000    0.120000
H     -4.136000    2.423000   -0.173000
C     -3.982000    5.109000   -0.311000
C     -1.125000    6.049000   -0.274000
H      0.291000   -2.100000    0.219000
C      2.983000   -2.010000    0.282000
C      4.016000    0.733000    0.147000
N     -0.217000   -0.053000    0.073000
N     -2.312000   -2.199000    0.070000
C     -4.632000   -1.543000    0.440000
C     -3.696000   -2.520000   -0.277000
H     -4.480000   -1.663000    1.536000
H     -4.635000    0.017000   -0.921000
H     -3.842000   -2.395000   -1.373000
H     -2.100000   -2.524000    1.041000
H     -4.697000    0.491000    0.739000
H     -1.673000   -2.640000   -0.629000
H     -5.697000   -1.757000    0.205000
H     -3.927000   -3.574000   -0.007000
H      1.252000    4.969000   -0.153000
H      2.939000    3.274000   -0.018000
H     -4.963000    4.589000   -0.313000
H     -3.909000    5.694000   -1.252000
H     -3.966000    5.796000    0.561000
H     -2.001000    6.721000   -0.336000
H     -0.504000    6.241000   -1.175000
H     -0.555000    6.340000    0.634000
H      2.441000   -2.978000    0.324000
H      3.597000   -1.927000    1.203000
H      3.649000   -2.034000   -0.606000
H      4.345000    1.781000    0.095000
H      4.485000    0.216000   -0.716000
H      4.437000    0.320000    1.087000











SOMSpec is a utility for predicting protein secondary structure from 
electronic spectra (such as circular dichroism (CD), infrared (IR/RAMAN). 
It does this through self organising maps – a form of machine learning.
Features
● Fast and flexible learning. A typical training run takes a few minutes on 
a recent desktop computer.
● Native support for Linux and Windows.
● Automated validation of training sets.




From this… to…  this.
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1. Select training set
2. Set parameters
This panel contains a





● The trained map is output to the same 
location as the training file.
● For a training set of ~50 spectra 
recommended settings are anywhere 
from 30 to 60 map size and 50,000 
iterations.




● Training set is a plain text .csv
● One column per spectrum – wavelength and 
step size arbitrary.
● Last cells of each column contain structure 
information.
In this example (an excerpt of the SP175 
dataset) cells 67 through 71 contain the 
fractions of: α-helix, β-sheet, turns, 
bends, and other – a total of 5 structures. 
These values must sum to 1.
Training set data format
(the reference dataset used for training the SOM)
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● Test set is a plain text .csv
● Multiple spectra can be input and predicted at 
the same time. Again, one column per 
spectrum – wavelength and step size 
arbitrary but must match training set 
wavelength range.
Columns ONLY contain spectrum data, 
no structure values – these will be 
predicted.
Test set data format







This panel displays the
selected pretrained
SOM parameters.




This function can be disabled.
Results are output in
Same location as input.
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● In this example 3 protein CD spectra were input (input file contained 3 columns.)
The predicted spectrum of each is output as a separate PDF.
● Secondary structure predictions
and other information is 
contained in the other files;
1 line per spectrum.
Results
(interpreting the output of a prediction)
● Goodness of fit (NRMSD) 




Other features - Validation of a training set
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SOMSpec is distributed licensed under the GPL3 license.
Download the installer (Linux & Windows) from somspec.org
Source code hosted at gitlab.com/daleang/somspec
Collaborators welcome.
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